WO1998045457A1 - Transgenic plants with modified sterol biosynthetic pathways - Google Patents

Transgenic plants with modified sterol biosynthetic pathways Download PDF

Info

Publication number
WO1998045457A1
WO1998045457A1 PCT/US1997/023495 US9723495W WO9845457A1 WO 1998045457 A1 WO1998045457 A1 WO 1998045457A1 US 9723495 W US9723495 W US 9723495W WO 9845457 A1 WO9845457 A1 WO 9845457A1
Authority
WO
WIPO (PCT)
Prior art keywords
sterol
plant
smt
dna
methyl
Prior art date
Application number
PCT/US1997/023495
Other languages
French (fr)
Inventor
W. David Nes
Original Assignee
Monsanto Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Company filed Critical Monsanto Company
Priority to EP97953327A priority Critical patent/EP0958370A1/en
Priority to CA002276087A priority patent/CA2276087A1/en
Priority to AU57099/98A priority patent/AU724046B2/en
Priority to BR9714439A priority patent/BR9714439A/en
Publication of WO1998045457A1 publication Critical patent/WO1998045457A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Definitions

  • the present invention broadly relates to plant genetic engineering. More particularly, it concerns the manipulation of the levels and/or activities of endogenous plant phytosterol compositions as a strategy for minimizing crop damage due to plant insects and other pests, and/or for improving the nutritional value of plants.
  • Sterols comprise a class of essential natural compounds required to some extent by all eukaryotic organisms. They have a common tetracyclic steroid nucleus and a side chain, as shown in the diagram below. Some sterols serve a structural role in cell membranes, while others are required during development.
  • Plants produce more than 250 different phytosterols (Akisha et al., 1992). As many as 60 sterols have been identified in the single species, Zea mays (corn) (Guo et al., 1995). However, insects, fungi and nematodes, as well as many other sterol-less parasitic organisms, do not synthesize all of their necessary sterols de novo. Rather, they satisfy their nutritional requirements for sterols by feeding on plants. This fact has been utilized in the development of commercial agrochemicals such as triazoles, pyrimidines and azasterols, which act by interfering with production of sterols within parasitic organisms.
  • the present invention broadly relates to approaches for genetically engineering plants to have altered sterol compositions, levels and/or metabolism. Such approaches can increase the plants natural insect resistance, can increase the plants resistance to drought and cold, and/or can improve the nutritional/health value of the plants.
  • recombinant DNA molecules comprising: a promoter which functions in plants to cause the production of an RNA sequence, operably linked to a DNA coding sequence encoding an enzyme which binds a first sterol and produces a second sterol, operably linked to a 3' non-translated region which causes the polyadenylation of the 3' end of the RNA sequence; wherein the promoter is heterologous with respect to the DNA sequence.
  • the DNA coding sequence encoding an enzyme which binds a first sterol and produces a second sterol can be in the sense or antisense orientation.
  • the DNA molecule of the invention can encode a non-translatable RNA molecule (e.g., antisense or cosuppression) or a protein molecule.
  • the RNA or protein so produced selectively targets the expression and/or activity of a sterol biosynthetic enzyme to affect a desired change in the phytosterol profile of the plant.
  • an approach for modifying the sterol composition of plants to increase their resistance to insects, nematodes, and pythiaceous fungi enhances the plant's ability to resist pests and disease by modifying the composition and/or distribution profile of certain phytosterols.
  • Such an approach overcomes many of the limitations inherent in the use of agrochemicals, or with transgenic plants where the foreign product introduced into the plant has the potential to eventually select for new mechanisms of resistance by the pest.
  • the present invention retains the benefits obtained through the use of agrochemicals, but avoids many of their disadvantages. By targeting an existing essential pathway in pests and pathogens, this invention reduces the likelihood of the evolution of mechanisms which circumvent this pathway.
  • Plant sterol composition is modified in this aspect by increasing the amount of non- utilizable sterols such as 4-methyl sterol, 9 ⁇ ,19-cyclopropyl sterol, ⁇ 7 -sterol, ⁇ 8 -sterol, 14 ⁇ -methyl sterol, ⁇ 23(24) -24-alkyl sterol, ⁇ 24(25) ,24-alkyl sterol or ⁇ 25(27) ,24-alkyl sterol.
  • sterol compositions can be modified to contain lower levels of sterols having a ⁇ 5 group.
  • Another aspect of the present invention relates to producing sterols in plants that confer resistance to drought and cold in plants.
  • Another aspect of the invention relates to altering the sterol profile of plants such that levels of cholesterol-lowering sterols are increased.
  • sterolic enzymes preferably S-adenosyl-L-methionine- ⁇ 24 -sterol methyl transferases (SMT T and SMT ⁇ ), C-4 demethylase, cycloeucalenol to obtusifoliol-isomerase, 14 ⁇ -methyl demethylase, ⁇ 8 to ⁇ 7 -isomerase, ⁇ 7 -sterol-C-5- desaturase, or 24,25-reductase.
  • SMT T and SMT ⁇ S-adenosyl-L-methionine- ⁇ 24 -sterol methyl transferases
  • C-4 demethylase cycloeucalenol to obtusifoliol-isomerase
  • 14 ⁇ -methyl demethylase ⁇ 8 to ⁇ 7 -isomerase
  • ⁇ 7 -sterol-C-5- desaturase or 24,25-reductase.
  • Another aspect of the invention is directed to transgenic plants having altered levels of selected sterols, produced by introducing recombinant DNA molecules of the invention into the genome of plant cells and selecting for cells expressing said molecule.
  • Transgenic plants are regenerated from the transformed plant cells and plants containing the recombinant DNA are grown to maturity. Plants expressing the recombinant DNA are identified and those having a desired sterol profile in accordance with the present invention are selected and propagated.
  • Fig. 1 shows HPLC radiocount (panel B) and mass spectrum (panel A) results of testing SMT enzyme with radiolabeled substrate co-factor;
  • Fig. 2 shows six inhibitors used to test the SMT enzyme
  • Fig. 3 shows SMT activity during seedling development
  • Fig. 4 shows the pathway of sterol end-products during development of seedlings
  • Fig. 5 shows the yeast SMT gene sequence (panel B; SEQ ID NO:l) and the deduced amino acid sequence (panel A; SEQ ID NO: 2) with the predicted conserved regions highlighted;
  • Fig. 6 shows the Arabidopsis SMT gene (panel B; SEQ ID NO: 3) and deduced amino acid (panel A; SEQ ID NO: 4) sequences;
  • Fig. 7 shows the ERG6 constructs prepared with pUC18cpexp expression cassette
  • Fig. 8 shows sequences of yeast SMT gene (SEQ ID NO: 5). Underlined sequences are those used as primers for screening genomic DNA from transgenic tomato plants; and
  • Fig. 9 shows structures of plant sterols tested on Heliothis zea and found to be utilizable or non-utilizable.
  • Figure 10 (SEQ ID NO: 6) shows the nucleotide and amino acid sequences of the corn SMT gene.
  • the phytosterol metabolic pathway consists of enzymes that act on the tetracyclic ring nucleus and the side chain.
  • the major pathway in advanced vascular plants starts from cycloartol (I):
  • the number of alternate pathways is sufficiently great to produce as many as 60 or more different sterols in a single plant. These alternate pathways vary according to tissue- and development-specific genetic programs.
  • the major pathway consists of the 12 chemical transformations as follows.
  • reaction 1 the enzyme S-adenosyl-L-methionine-sterol-C-24 methyl transferase -(SMTj) catalyzes the transfer of a methyl group from a cofactor, S-adenosyl-L- methionine, to the C-24 center of the sterol side chain.
  • SMTj the enzyme S-adenosyl-L-methionine-sterol-C-24 methyl transferase -(SMTj) catalyzes the transfer of a methyl group from a cofactor, S-adenosyl-L- methionine, to the C-24 center of the sterol side chain.
  • SMTj the enzyme catalyzes the transfer of a methyl group from a cofactor, S-adenosyl-L- methionine, to the C-24 center of the sterol side chain.
  • SMT ⁇ catalyzes the conversion of cycloartol to a ⁇ 23(24) 24-alkyl sterol, cyclosadol (Guo et al., 1996).
  • Reaction 2 involves a demethylation at C-4. This is the first of several demethylation reactions in the nucleus.
  • 24(28)-Methylenecycloartanol Reaction 3 involves opening the cyclopropyl ring at C-9(10) by the enzyme cycloeucalenol-obtusifoliol isomerase (COI), which also creates a double bond at C-8.
  • COI cycloeucalenol-obtusifoliol isomerase
  • Reaction 4 involves a demethylation at C-14 which removes the methyl group at C-14 and creates a double bond at C-14.
  • Reaction 5 is catalyzed by a ⁇ 14 reductase.
  • Reaction 7 is a second C- methylation of the sterol side chain.
  • the reaction is catalyzed by SMTj, the same enzyme that initiated the major pathway.
  • Reaction 8 involves a C-4 demethylase to generate a 4,4-desmethyl sterol.
  • -10- (citrastadienol) Reaction 9 involves a ⁇ desaturase, producing a double bond at C-5 in the tetracyclic ring.
  • reaction 9 The product of reaction 9 is then transformed in reaction 10 by a ⁇ 7 -reductase by removing the double bond at C-7.
  • Reaction 11 involves a ⁇ 24(28) - to ⁇ 24(25) -isomerase which modifies the side chain. (It is believed that this reaction would have proceeded from the product of reaction 5 if the kinetics were more favorable.)
  • Reaction 12 the ⁇ 24(25) double bond at C-24 is reduced stereoselectively to produce sitosterol (II).
  • SMT T and SMT ⁇ Two different SMT enzymes exist (SMT T and SMT ⁇ ) whose expression depends on the tissue and stage of differentiation. Blades mainly contain 24- ethyl sterols (resulting from the activity of SMT T ), whereas the sheaths contain mainly 24-methyl sterols (VI) (resulting from the activity of SMT ⁇ ). These sterols are the products of the two different SMT enzymes that react with the same starting material, cycloartenol.
  • the first enzyme, SMTi produces ⁇ 24(28) -methylene and the second enzyme produces ⁇ -methyl sterol (V).
  • the first isoform leads to a utilizable sterol (a sterol which can be utilized by insects, pythiaceous fungi, and nematodes to complete their life cycles).
  • the second isoform produces a non-utilizable sterol (a sterol which cannot be utilized by insects, pythiaceous fungi, and nematodes to complete their life cycles). Therefore, one could inhibit expression of the first isoform so as to cause accumulation of the non- utilizable ⁇ 23(24) -methyl sterols.
  • the sterols that accumulate in the tissue contain a double bond at C-23 (VI) and a methyl at C-24.
  • a recombinant DNA molecule of the invention generally comprises a promoter region capable of causing the production of an RNA sequence in plants, a structural DNA sequence, and a 3' non-translated region.
  • promoter region contains a sequence of bases that signals RNA polymerase to associate with the sense and antisense DNA strands and to use the sense strand as a template to make a corresponding strand of mRNA complimentary to the sense DNA strand.
  • This process of mRNA production using a DNA template is commonly referred to as gene "expression” or “transcription” .
  • the promoter is heterologous with respect to the DNA coding sequence.
  • heterologous with respect to a promoter means that the DNA coding sequence of a recombinant DNA molecule of the invention is not derived from the same gene to which the promoter is attached.
  • Promoters may be obtained from a variety of sources, such as plants and plant viruses.
  • the particular promoters selected for use in embodiments of the present invention should preferably be capable of causing the production of sufficient expression to affect the desired change in the sterol distribution profile of the plant.
  • CaMV cauliflower mosaic virus
  • FMV Figwort mosaic virus
  • the sugarcane baciUiform virus promoter (Bouhida et al., 1993), the commelina yellow mottle virus promoter (Medberry and Olsewski 1993), the light-inducible promoter from the small ⁇ subunit of the ribulose-l,5-bis-phosphate carboxylase (ssRUBISCO) (Coruzzi et al., 1984), the rice cytosolic triosephosphate isomerase (TPI) promoter (Xu et al. 1994), the adenine phosphoribosyltransferase (APRT) promoter of Arabidopsis (Moffatt et al. 1994), the rice actin 1 gene promoter (Zhong et al. 1996), the mannopine synthase and octopine synthase promoters (Ni et al. 1995). All of these promoters have been used to create various types of DNA constructs which have been expressed in plants.
  • Recombinant DNA molecules also typically contain a 5' non-translated leader sequence.
  • This sequence can be derived from the promoter selected to express the gene, and if desired, can be specifically modified so as to increase translation of the mRNA.
  • the 5' non-translated regions can also be obtained from viral RNAs, from suitable eukaryotic genes, or from synthetic gene sequences.
  • the structural DNA sequence of the recombinant DNA molecule of the invention will cause the desired alteration in the sterol profile of the plant, as discussed further below.
  • the 3' non-translated region of a recombinant DNA molecule of the invention can be obtained from various genes which are expressed in plant cells. For example, the nopaline synthase 3' untranslated region (Fraley et al. 1983), the 3' untranslated region from pea ssRUBISCO (Coruzzi et al. 1994), and the 3' untranslated region from soybean 7S seed storage protein gene (Schuler et al. 1982) are frequently used.
  • the 3' non-translated region of a recombinant DNA molecules contains a polyadenylation signal which functions in plants to cause the addition of adenylate nucleotides to the 3' end of the RNA.
  • intron sequences are frequently included in recombinant DNA molecules used for producing transgenic plants in order to enhance expression levels.
  • plant introns suitable for expression in plants can include maize hsp70 intron, rice actin 4 intron, maize ADH 1 intron, Arabidopsis SSU intron, Arabidopsis EPSPS intron, petunia EPSPS intron and others known to those skilled in the art.
  • a double stranded DNA molecule of the present invention can be inserted into the genome of a plant by any suitable method.
  • Numerous plant transformation methods have been described, including Agrobacterium-mediated transformation, the use of liposomes, electroporation, chemicals that increase free DNA uptake, free DNA delivery via microprojectile bombardment, transformation using viruses or pollen, etc.
  • Transformation of monocots using electroporation, particle bombardment, and Agrobacterium have also been reported. Transformation and plant regeneration have been achieved, for example, in asparagus (Bytebier et. (1987)), barley (Wan and Lemaux (1994)), maize (Rhodes et al. (1988); Gordon-Kamm et al. (1990); Fromm et al. (1990); Koziel et al. (1993); Armstrong et al. (1995)), oat (Somers et al. (1992)), orchardgrass (Horn et al. (1988)), rice (Toriyama et al. (1988); Battraw and Hall (1990); Christou et al.
  • a series of phytosterols were tested in insects and many were found to be unable to support insect growth, i.e., were non-utilizable. These sterols included 9,19- cyclopropyl sterols. Furthermore, novel ⁇ (23(24) - and ⁇ 24(25) -alkene and ⁇ 25(27) -alkyl sterols were also determined to be unable to support insect growth and maturation. These were tested in vivo using Heliothis zea (a corn earworm), cultured on synthetic media that was sterol-free with the exception of added test sterols. It was found that if the ratio of utilizable to nonutilizable sterols was 1:9 or less, insects could not undergo normal develop. In fact, even at 1:1 ratios, insect development was adversely affected.
  • insects The metabolism of insects, nematodes and pythiaceous fungi is limited by the availability of major plant sterols. These pests cannot use a sterol with a C-4 methyl group; a 9 ⁇ , 19-cyclopropyl group, or a ⁇ group. Furthermore, nematodes and insects cannot utilize 14- ⁇ methyl-sterols, and some insects, including lepidoptera, diptera and coleoptera, cannot utilize C-24 alkyl sterols with ⁇ 24(25) , ⁇ 23(24) , or ⁇ 25(27) groups for mechanistic reasons. Some insects cannot utilize sterols lacking a ⁇ 5 group. Consequently, elevation of these sterols in plants would provide a detrimental dietary source of sterols for these pests.
  • the DNA molecule of the present invention when expressed in transgemc plants, will cause alterations in the composition/distribution of the sterols present in the plant.
  • the DNA molecule causes the accumulation of sterols that are non-utilizable by insects and other pests, so as to increase the plants resistance to the organisms. This can be accomplished, for example, by a number of approaches, including overexpression, antisense, cosuppression etc.
  • the DNA molecule of the invention will typically target an endogenous gene encoding an enzyme selected from the kinetically favored pathways of sterol biosynthesis.
  • gene expression and/or translation of a sterol biosynthetic enzyme is targeted for inhibition.
  • This inhibition can be achieved, for example, by engineering a DNA molecule of the invention to produce an antisense, ribozyme or cosuppression RNA molecule complementary to an endogenous gene being targeted.
  • Approaches for the targeted inhibition of gene expression are well known to the skilled individual (for reviews, see Bird et al., 1991; Schuch, 1991; Gibson et al., 1997)
  • a preferred target for inhibition is the S-adenosyl-L-methionine- ⁇ 24(25) -sterol methyl transferase (SMT) enzyme.
  • SMT S-adenosyl-L-methionine- ⁇ 24(25) -sterol methyl transferase
  • RNA or protein molecule capable of modifying the sterol composition of the plant in a desirable manner.
  • C-4 demethylase This enzyme is involved in the removal of the two methyl groups at C-4 and represents reactions 2 and 8 in the description section. A single protein is responsible for both the reactions. Blocking this enzyme will lead to accumulation of 4,4-dimethyl sterols such as cycloartol, 24(28)-methylene eycloartenol or a novel sterol such as 24-dihydrolanosterol (structure 18 in Fig. 9). All these are nonutilizable sterols. This may be achieved through suppression of this gene in plants.
  • ⁇ 7 -sterol-C-5-desaturase This is reaction 9 in the pathway. Inhibition of this enzyme leads to a depletion of ⁇ 5 -sterols and an increase in ⁇ 7 -sterols. Certain insects are known to be unable to metabolize ⁇ 7 -sterols into ecdy steroids. Therefore, accumulation of ⁇ -sterols in plants can also provide a way to form non-utilizable sterols. Further, ⁇ 7 -sterols can replace ⁇ 5 -sterols in plant membranes without any morphological changes in plant development.
  • C-24 reductase This is the terminal step in phytosterol transformation (reaction -12) during the formation of sitosterol, the major ⁇ 5 -sterol in plants. Disruption or suppression of the gene encoding this enzyme would result in the accumulation of ⁇ 24(25) -24-alkyl sterols which are also non-utilizable.
  • genes encoding these preferred sterol biosynthetic enzymes to be targeted by the present invention have been isolated from yeast (for review, see Lees et al., 1997). Some have been isolated from plants. For example, SMT genes have been isolated from soybean (Shi et al., 1996), arabidopsis (Husselstein et al., 1996; Bouvier- Nave et al., 1997) tobacco and castor (Bouvier-Nave et al., 1997); and corn (Grabenok et al., 1997).
  • the gene encoding a sterol biosynthetic enzyme can be readily isolated from a desired source by approaches known to the skilled individual. For example, an isolated gene or cDNA from one source can be used as a hybridization probe for the isolation of homolgous sequences from other sources.
  • a DNA molecule of the invention should be active in numerous plant types, regardless of the source of the sterol biosynthetic gene used in the targeting construct, given the successful demonstration provided herein of using a yeast ERG6 antisense construct to alter the sterol profile in tomato.
  • the following sterolic metabolic enzymes are targeted for inhibition: S- adenosyl-L-methionine- ⁇ 24 -sterol methyl transferase, C-4 demethylase, cycloeucalenol to obtusifoliol-isomerase, 14 ⁇ -methyl demethylase, ⁇ 8 - to ⁇ 7 -isomerase, ⁇ 7 -sterol-C-5- desaturase, or a 24,25-reductase.
  • Plants produced according to this embodiment preferably have increased amounts of certain sterols that are non-utilizable, particularly 4-methyl sterol, 9 ⁇ ,19-cyclopropyl sterol, ⁇ 8 -sterol, ⁇ 7 -sterol, 14 ⁇ -methyl sterol, ⁇ 23(24) ,24-alkyl sterol, ⁇ 24(25) -24-alkyl •sterol or ⁇ 25(27) -24-alkyl sterol, or decreased levels of sterols having a ⁇ 5 group.
  • Preferred crops for use in providing insect resistance according to this embodiment of the invention include com (European com borer, com earworm, fall armyworm), rice, sorghum, forestry, potato, tomato (tomato hornworm), and vegetable brassicas.
  • Preferred crops for use in providing nematode resistance according to this embodiment of the invention include soybean (soybean cyst nematode), tomato (root knot nematode), sugarbeet and cucurbits.
  • Preferred crops for use in providing fungal resistance include corn, rice, wheat, surghum, soybean (Phytophthora root rot), sunflower, forestry, fruits and berries, potato (late blight), tomato (late blight), sugarbeet, cucurbits, and vegetable brassicas.
  • the present invention in another embodiment, relates to increasing cholesterol- lowering sterols in transgenic plants.
  • a recombinant DNA molecule of the invention the conversion of cycloartol in developing seeds can be inhibited, for example by antisense, cosuppression, or ribozyme-mediated inhibition of SMT expression, thereby leading to an accumulation of this sterol in seed oils.
  • the SMT gene can be overexpressed in order to increase the levels of sitosterol.
  • Preferred crops for use in accordance with this embodiment of the invention include sunflower, corn, soybean, oilseed brassicas and cotton.
  • Another embodiment of this invention derives from the fact that certain sterols are associated with reducing water permeability of membranes. For this reason, sterol manipulation should provide an effective means for preventing or at least minimizing drought induced damage.
  • nonutilizable sterols in plants through the various gene manipulation strategies described in this invention will not only protect the plants from pests and pathogens but also from environmental stresses such as drought and cold.
  • Preferred sterols to be elevated in this aspect include ⁇ 5 -24 alkyl sterols, such as 24-methyl cholesta-5,23-dienol, and cycloartenol.
  • Preferred crops for use in accordance with this embodiment of the invention include com, wheat, rice, sorghum, soybean, oilseed brassicas (rapeseed, canola), sunflower, palm, peanut, cotton, forestry, fruits, berries, nuts, potato, tomato, sugarbeet, sugarcane, cucurbits (squash, melons, cucumbers, watermelons, pumpkins), vegetable brassicas, alfalfa, ornamental crops, turfgrass, peanut, tea and coffee.
  • Sterol isomers were extracted from corn and were isolated to homogeneity using chromatographic methods. Novel phytosterols were identified with side chains that have been found to be non-utilizable in insects.
  • the sterols were structurally characterized by mass spectroscopy and 1H and 13 C nuclear magnetic resonance (NMR) (Table 1) (Guo et al, 1995).
  • Obtusifoliol 426 0.25 c, g, r, sh, b, p
  • Citrastadienol 426 0.25 c, g, r, sh, b
  • Campesterol 400 0.18 st, c, g, sh, b, r, t, p
  • Isofucosterol 412 0.18 st, c, g, sh, b, r, t, p
  • Stigmasterol 412 0.18 st, c, g, sh, b, r, t, p
  • Sitosterol 414 0.18 st, c, g, sh, b, r, t, p
  • sterols in blades contain mainly 24-ethyl sterols, e.g., sitosterol, while sheaths contained mainly 24-methyl sterols, e.g., 24-methyl-cholesta-5 ,23-dienol .
  • 3C and 3D show: (1) that SMT activity is correlated with sterol synthesis and plant growth; (2) neither sitosterol nor 24(28)-methylene cycloartanol at 100 mM affected HMGR activity, suggesting that HMGR activity does not correlate to growth or sterol production; and (3) the rate of phytosterol turnover correlates to the activities of the first and second methylation of SMT ! enzyme and not HMGR activity.
  • Fig. 4 summarizes the pathway to kinetically favored ⁇ 5 -24-alkyl sterol end products in com during development of the seedling into blades and sheaths under dark-grown conditions.
  • SMT enzyme activities during early blade and sheath formation, and sterol specificity data show that com synthesizes at least two different SMT enzymes: SMT ! catalyzes the successive methyl transfer to produce ⁇ 24(28) -methylene and ⁇ 24(28) -ethylidene sterols; and SMT ⁇ catalyzes the methyl transfer to ⁇ 23(24) -24-methyl sterols.
  • Example 1 The phytosterols identified in Example 1 were tested individually for their ability to support growth. In the absence of a plant sterol mutant for such studies the yeast sterol auxotroph, GL-7, was cultured in the presence of sterols identified according to Example 1, above (Li, 1996). This yeast mutant is used as a model system because it can take up sterols from the culture medium and incorporate the test sterol into the membrane lipid bilayer and proliferate. The amount of proliferation of the cells was measured in the presence and absence of hormonal levels of ergosterol, the major yeast sterol.
  • Sterols were classified according to their effect on growth. Those sterols sparking growth included ergosterol. Those sterols that migrated to membrane and cell structural components without affecting the rate of growth of the cells included cholesterol and sitosterol (Nes et al., 1993).
  • the sterol specificity of the microsome-bound and soluble SMT enzyme from 4-day com seedlings was determined in order to elucidate the enzymatic basis for the plant sterols identified in Example 1.
  • cycloartol is the preferred sterol acceptor and that 24(28)-methylene lophenol was methylated to produce 24(28)-ethylidenelophenol.
  • Table 2 summarizes the specificities to various sterol substrates using the soluble SMT enzyme from com seedlings.
  • the com SMT protein is a tetramer with 4 subunits of 39 kDa.
  • a bifunctional sterol- methylating (SMT) enzyme was partially purified from 4-day etiolated Zea mays (com) shoots by the following steps:
  • non-ionic detergent solubilization of the microsome-bound SMT enzyme (i) non-ionic detergent solubilization of the microsome-bound SMT enzyme; (ii) gel-filtration fractionation of the solubilized protein to produce active fractions with an apparent native molecular weight of circa 156 kd; and (iii) hydroxyapatite chromatography of active fractions.
  • Fig. 1 shows an HPLC-radiocount (Fig. IB) and mass spectrum (Fig. 1A) of the reaction product from 50 pooled assays from a soluble SMT enzyme (4-day seedlings) assayed with 24(28)-methylene lophenol. The second methyl transfer from 24(28)-methylene lophenol to 24(28)-ethylidene lophenol is demonstrated in this incubation.
  • SMT enzyme from 4-day corn shoots catalyzes the successive first and second methyl transfers of an appropriate sterol acceptor molecule.
  • Table 3 shows the effect of a series of substrate and transition state analogs on the first and second methyl transfer reactions.
  • cycloartol ( ⁇ 24 -4,4-dimethyl sterol) with 20 mM Km and 4 pmol/min mg protein Ymax; and 24(28)-methylene lophenol ( ⁇ 7 ,24(28)-4-monomethyl sterol) with 11 ⁇ M Km and 1 pmol/min/mg protein Vmax.
  • cycloartol was the preferred substrate for the first methylation reaction
  • 24(28)-methylene lophenol was the preferred sterol substrate for the second methylation reaction.
  • Zymosterol ( ⁇ 8 ' 4 -4-desmethyl sterol), a preferred sterol substrate of yeast SMT enzyme, was a poor sterol substrate of the first methylation reaction.
  • binding site I catalyzes a first methyl transfer to produce a 24(28)-methylene sterol
  • binding site II catalyzes the second methyl transfer to produce a 24(28)-ethylidene sterol.
  • sitosterol 24 ⁇ -ethyl cholesterol
  • campesterol 24 -methyl cholesterol
  • campesterol 24 -methyl cholesterol
  • 24(28)-methylenecycloartanol a product of cycloartanol transmethylation, was not methylated
  • 24(28)-methylenecycloartanol inhibited the first methyl transfer (20 ⁇ M K,) whereas it failed to inhibit the second methyl transfer.
  • 26,27-cyclopropylidene cycloartol which failed to bind to the yeast SMT enzyme, was a potent competitive inhibitor of the first methylation reaction (25 ⁇ M K,), while not affecting the second methyl transfer.
  • the second alkylation was inhibited by product inhibition from 24(28)-ethylidene lophenol (75 mM K,), while not affecting the first methyl transfer.
  • a transition state analog, 24-(R,S)-25-epiminolanosterol inhibited the first and second methylation reactions with a similar K, value of 55 nM and to exhibit a non-competitive type kinetic pattern.
  • the sterol features of the substrate in the initial enzyme-substrate interaction appears to be typical of other plant SMT enzymes, i.e., a requirement for nucleophilic groups at C-3 and C-24.
  • the 5 ⁇ M K m for the coenzyme was the same for the first and second methylation reactions.
  • the yeast SMT gene, ERG6 was derived from a yeast ERG6 genomic fragment, pRG458/erg6 (Fig. 5B; SEQ ID NO:l).
  • the cloned ERG6 gene was expressed in E. coli.
  • the recombinant protein was shown to be the sterol biomethylation enzyme by enzymatic study which proved that the kinetic properties were similar to that of the native enzyme in yeast.
  • zymosterol a ⁇ 24 -4-desmethyl sterol
  • the molecular weight of the yeast SMT monomer was confirmed to be 43 kD after successfully overexpressing the active protein in E. coli using a T7 promoter-based pET23a(+) vector.
  • the overexpressed protein was visualized on SDS-PAGE gel both by Coomassie blue staining and Westem blot using a yeast SMT polyclonal antibody.
  • the recombinant protein has also been purified from this system.
  • Fig. 5A From the deduced amino acid sequence of the yeast SMT (Fig. 5A; SEQ ID NO:2) the potential AdoMet binding motif was predicted as the first conserved region identified in Fig. 5A (YEYGWGS) and based on mechanistic analysis of biomethylation described in Example 3, the amino acid tryptophan (W) was determined to be the binding site. By -site-directed mutagenesis of the ERG6 gene this amino acid was replaced with alanine. The mutated DNA was also overexpressed in E. coli by cloning into pET23a( +). This protein was not active under conditions where the wild-type protein was active.
  • Such a strategy provides a means to alter phytosterols by introducing inactive SMT protein into plants.
  • the introduction of non-functional SMT monomers can result in the suppression of SMT activity, for example by affecting the ability of the cell to form a functional SMT enzyme complex, thereby leading to the formation of nonutilizable sterols.
  • suppressing the activity of the first SMT Z reaction will lead to formation of ⁇ 23(24) -24-alkyl sterols, products of SMT ⁇ activity.
  • suppressing the activity of the second SMT : reaction will lead to the formation of ⁇ 24 25) - 24-alkyl sterols.
  • the SMT gene from Arabidopsis was cloned and sequenced (Fig. 6; SEQ ID NO:3). This gene was overexpressed in E. coli. Arabidopsis SMT was partially purified and characterized in stereochemical detail.
  • the Arabidopsis SMT gene was amplified by PCR from a cDNA library.
  • the primers used were designed from the full-length cDNA sequence retrieved from the GeneBank (Accession number X89867).
  • the amplified product was the full-length Arabidopsis SMT gene which was sub-cloned into a T/A cloning vector and sequenced. From the sequence data the ORF was identified. A Nde I site was created at the ATG start codon through PCR mediated site-directed mutagenesis.
  • the full-length ORF containing a Nde 1 site at the start and a BamH I site at the stop was cloned into the pET23a(+) vector just as the ERG6 gene was in Example 4.
  • the recombinant protein was active in transforming both cycloartol and 24(28)-methylene lophenol to their respective alkyl products (Tong et al, 1997).
  • cycloartanol only one product was formed, which is 24(28)-methylene cycloartanol, i.e., SMTj in Fig. 4.
  • SMTj 24(28)-methylene cycloartanol
  • the com sterol methyl transferase (SMT) gene was isolated from a commercial com cDNA library (Stratagene, La Jolla, CA). Five microliters of com cDNA (equivalent to 5x10 pfu) were used as template in the amplification of the SMT gene by polymerase chain reaction (PCR). Because the cDNA library was constructed in the vector Uni-Zap
  • PCR amplification (3 'end primer).
  • the 5' end primer (2650-1) was designed from nucleotides 2-20 of a putative SMT fragment published in Gene Bank (T23297). Thirty cycles of PCR were conducted using five units of Taq polymerase from Promega in a total volume of 100 microliters, according to the manufacturer's instructions. One microliter of PCR product from this reaction was used as the template for a second round of PCR using the T7 primer and a primer designed from nucleotides 250-268 of T23297. When the resulting reaction products were analyzed on a 1 % agarose gel, a band of 1.3 kb was seen. This PCR band was subcloned into the plasmid pGEM-T
  • the cloned SMT cDNA was 1497 nucleotides, with a coding region of 1032 nucleotides, which encodes 344 amino acids (Figure 10; SEQ ID NO: 6).
  • the start codon, ATG was located at nucleotide 66-68.
  • a poly A tail of 28 nucleotides was located 371 nucleotides downstream of the stop codon, indicating the cDNA fragment was complete at 3 'end. Therefore, this cDNA clone is a full length cDNA clone.
  • the deduced amino acid sequence from this cDNA clone contains 344 amino acids, encoding a polypeptide of 38.8 kiloDaltons.
  • This deduced amino acid sequence contains all three of the proposed conservative regions for methyl transferase (Kagan and Clarke, 1994. Arch. Biochem. Biophys. 310: 417-427): LDVGCGIGGP at position 104-114 (amino acid sequence) and TLLDAVYA at position 167-174, and VLKPGQ at position 194-199.
  • Another conserved region for sterol methyl transferase proposed by Nes (SFYEYGWGESFHFA, Guo et al.,1997. Antifungal sterol biosynthesis inhibitors.
  • Cholesterol Its function and Metabolism in Biology and Medicine, edited by Robert Bittman. Plenum Press, New York
  • the deduced com SMT amino acids sequence was compared with amino acid sequences from other known SMT genes using GCG progams (Gap and Bestfit).
  • the deduced corn SMT amino acid sequence shared a 93.6% similarity with an independently isolated corn SMT sequence (Genbank U79669), 88.1 % homology, 78.8% identity with soybean SMT (Genbank U43683), and a 93.9% homology, 88.3% identity with partial wheat SMT sequence (Genbank U60754 ), 58.8% homology, 39% identity with Arabidopsis thaliana (Genbank X89867), and a 66.5% homology, 50.4% identity with -yeast SMT (Genbank X74249).
  • this cDNA clone is a full length SMT cDNA clone of Zea mays. Furthermore, since Grabenok et al. have functionally expressed their com SMT gene in a yeast expression system and found no 24-alkyl sterols other than ergosterol, this suggests that the com SMT gene isolated by my laboratory catalyzes the same stereoselective C-methylation to ⁇ 24(28) , thereby supporting the view that com synthesizes several different SMT enzymes.
  • cDNA fragments isolated by the described method should be representative of both SMTj and SMT ⁇ based on the conservation of the region from which the primers were derived.
  • SMT gene Another example of a preferred SMT gene is that from Prototheca wickerhamii. This yeast-like alga produces ⁇ 25 27) -24-methyl sterol as the main product of transmethylation.
  • the favored substrate is cycloartol.
  • the preferred substrate of the SMT is cycloartol.
  • the preferred product is not 24(28)- methylene cycloartol but cyclolaudenol (VII) which is a ⁇ 25(27) -24-alkyl sterol, a nonutilizable sterol.
  • Cloning the gene of this SMT will facilitate the introduction of this gene into plants in order to transform the plant sterol, cycloartol, into a product, cyclolaudenol, which will lead to the accumulation of nonutilizable sterols, viz., ⁇ 25(27) -24-alkyl sterols.
  • Prototheca wickerhamii cells are grown to mid log phase in YPD rich medium (yeast extract - peptone - dextrose). The pelleted cells are disrupted in the presence of Tri Reagent (MRC) using 0.5 mm glass beads and a mini-Beadbeater (both from Biospec Products, Bartlesville, OK). High quality total cellular RNA is isolated according to the manufacturer's instructions.
  • YPD rich medium yeast extract - peptone - dextrose
  • Total cellular RNA is subjected to 3' RACE (rapid amplification of cDNA ends) and 5' RACE using reagents and protocols found in kits obtained from GibcoBRL.
  • 3' RACE total cDNA is synthesized by the action of reverse transcriptase after annealing oiigo(dT)-containing primers to the poly(A)-tailed RNAs present in the unfractionated total RNA.
  • the RNA templates are degraded and the cDNA serves as template for polymerase chain reaction (PCR) amplification.
  • PCR polymerase chain reaction
  • the user-supplied primer "YEYGWG” (see Rationale for primer design below) anneals to the cDNA and is extended toward the 3' end of the gene under the direction of Taq polymerase.
  • the kit-supplied primer for extension from the 3' end to the terminus defined by the "YEYGWG” primer anneals to a sequence composed of three restriction endonuclease recognition sites that was part of the original oligo-dT containing primer.
  • Another nested primer (“ATCHAP”) has been similarly used.
  • RNA Total cellular RNA is also subjected to 5' RACE.
  • cDNA is synthesized by reverse transcriptase using the antisense primer "EWVMTDas".
  • cDNA is modified at the 3' end by the addition of a polydeoxycytidine "tail" using terminal deoxynucleotidyl transferase (TdT).
  • TdT terminal deoxynucleotidyl transferase
  • An initial PCR reaction is carried out using this C-tailed cDNA as template and the primers "EWVMTDas" and a kit-supplied poly-G containing primer.
  • a second PCR reaction is carried out on this PCR product using the nested primer "ATCHAPas” and a kit-supplied primer that anneals to a part of the poly-G primer that contains restriction enzyme recognition sites. This second PCR reaction enriches for 5' SMT cDNA sequences.
  • the 3' RACE and 5' RACE PCR products are isolated from gels and ligated into the plasmid pPCRII (Invitrogen). Clones obtained after transformation into E. coli are characterized by sequencing. An Apa I restriction site is present in the DNA of all plants and yeast that have been sequenced in the GCGVGG motif and is present in both the 3' and 5' cDNA clones. This allows splicing of the two 3' and 5' halves of the SMT gene together, completing the entire coding region.
  • the first step in designing the user-supplied primers was to examine the several very highly conserved peptide motifs in the SMTs of those plants and yeast that have been sequenced. Within these are found shorter stretches of amino acid sequences that can be encoded by a minimum number of DNA sequences, the codons of which usually only vary at the third (degenerate) base. It was also desirable that the codon preferred by 3 different yeast species according to codon usage tables found in Wada, et. al. (Nucleic Acids Res., vol 19, pi 981, 1991) be present in the mix of degenerate codons for each amino acid. Each user defined primer is thus a mixture of deoxynucleotides that defines an internal end of a PCR product. It was also reqiured that 4 or 5 of the 6 3' deoxynucleotides of each primer be perfectly matched in all species and had greater than
  • the first three primers described below are sense orientation primers that anneal to -antisense DNA (and the original cDNA).
  • the fourth and fifth primers are antisense primers that anneal to the sense DNA strand of the SMT gene.
  • YE[Y/F/W]GWG (amino acids 81-86 of the yeast sequence; nonidentical residues at a position are in brackets) was the part of a larger conserved region of SMT that was the basis for the "YEYGWG" primer:
  • GCGVGG The "GCGVGG” primer was suggested by the DNA sequence that encodes part of a second conserved domain (GCG[V/I]GG) at yeast amino acid residues 129-134.
  • the sequence of primer "GCGVGG” is:
  • Primer "ATCHAP” is based on the DNA sequence encoding a third highly conserved domain (yeast amino acids 196-203).
  • the primer sequence is:
  • EWVMTDas is an antisense primer for first strand cDNA synthesis in the 5' RACE experiment. It is based on the small conserved domain at yeast amino acid residues 225-231. The sequence is:
  • ATCHAPas is a nested antisense primer for the 5' RACE experiment with the sequence:
  • cDNA libraries from any crop of interest can be screened and corresponding clones of appropriate sizes can be isolated and sequenced.
  • cDNA library construction and screening methodologies are well known in the art.
  • appropriate primer combinations can be readily determined using information of the conserved regions of known sequences for various SMT genes. To confirm the identity of sequences cloned by this method, they can be compared with known plant SMT enzyme sequence and/or in vitro tranlsated and evaluated biochemically.
  • Example 4 To obtain transgenic plants with altered sterol profiles a DNA fragment containing the open reading frame of the SMT ERG6 gene of yeast isolated from a genomic clone was identified (Example 4).
  • the ERG6 DNA was modified by PCR to include restriction sites for Nco I on either end of the open reading frame. This PCR procedure gave ruse to a mutaion which introduced a frameshift in the gene. This mutation made the ERG6 gene introduced into the plant untranslatable, but capable of inhibiting the endogenous tomato SMT via antisense or co-suppression mechanisms, depending upon the nature of the construct.
  • the modified ERG6 DNA fragment was cloned into the pUCl ⁇ cpexp expression cassette vector. Clones with the ERG6 DNA in the sense as well as the antisense orientations to the 35S promoter were generated (Fig. 7).
  • Hind HI digestion of these clones gave rise to the ERG6 constructs that included the 35S promoter and termination sequences flanking the ERG6 open reading frame. These Hind III digested fragments were cloned to the binary vector pJTS246 that contains T-DNA border recognition sequences and the NPTII gene conferring kanamycin resistance.
  • the cloned binaries with either the sense or antisense ERG6 constructs were transformed into Agrobacterium tumefaciens which were cocultivated with cotyledons of tomato (Solanum lycoperiscum) to obtain transformed plant cells. From calli formed on selective medium containing kanamycin transgenic plants were produced.
  • the leaves from control (no inserts) and transgenic plants (with inserts) were analyzed for the transgene.
  • DNA was extracted from leaf samples of each of the transformants and an untransformed tomato plant. The DNA extracts were quantified by A260 absorbance.
  • ERG6 sequence (underlined in Fig. 8). Controls in the PCR included a sample with no template DNA and samples of the sense and antisense ERG6 containing binary plasmids.
  • PCR was performed under non-stringent conditions (55 °C annealing temperature for 2 min in each cycle) in 20 cycles and aliquots were electrophoresed on 0.8% agarose gels.
  • the primers were selected such that a 1100 bp fragment of the ERG6 DNA would be amplified (Fig. 8). All the regenerated transgemc tomato plants (Ro) carried this fragment as did the plasmid controls. There also is some non-specific amplification because of the non-stringent conditions leading to other bands appearing in the transformed plants and in the untransformed control. However, the level of these amplifications is significantly less than that of the target fragment. This confirms the presence of the ERG6 DNA in the tomato genome. Sterol analysis was performed on the nonsaponifiable lipid fraction of leaf material frqm -one regenerated plant transformed with the sense construct and one regenerated plant transformed with the antisense construct. The results are shown in Table 4.
  • a scheme for the new pathway introduced into the tomato plants due to the insertion of the yeast ERG6 gene is predicted to be as follows:
  • the regenerant (RQ) plants were allowed to flower and set fruit. Seeds were collected, and the following generation (R-T) was grown. Individual plants arising from seeds were assayed for the presence or absence of the selectable marker (NPT2) via ELISA assay for the NPT2 protein. Fifty-three plants from six Rj progeny and a nontransgenic plant were analyzed for sterol composition. The sterol profiles of these plants could be divided into four distinct groups, or phenotypes: Table 5
  • Plant Nontransformed G55 (nontransgenic G62 (nontransgenic Mean Std. segregant) segregant) Dev.
  • Obtusifoliol 1 - tr. 1.0 -dash lines means not detected; tr. is trace; N.D.-not determined.. NSF was chromatographed on TLC plates and bands matching 4-desmethyl-, 4-monomethyl and 4,4-dimethyl sterol standards were eluted from the plate and examined further by chromatography on 3% SE-30 columns and GC-MS. Limit of detection is 0.1 mg sterol per leaf sample. These controls can be compared with transgemc plants, the sterol composition of which are given in tables 8, 9, and 10. Table 8 Sterol composition of transgenic plants from line G3
  • NSF was chromatographed on TLC plates and bands matching 4-desmethyl-, 4- monomethyl and 4,4-dimethyl sterol standards were eluted from the plate and examined further by chromatography on 3% SE-30 columns and GC- MS. Limit of detection is 0.1 mg sterol per leaf sample.
  • Obtusifoliol tr. 1 1 tr. - tr. tr. tr. 1
  • NSF was chromatographed on TLC plates and bands matching 4-desmethyl-, 4-monomethyl and 4,4- dimethyl sterol standards were eluted from the plate and examined further by chromatography on 3% SE-30 columns and GC-MS. Limit of detection is 0.1 mg sterol per leaf sample.
  • NSF was chromatographed on TLC plates and bands matching 4-desmethyl-, 4- monomethyl and 4,4-dimethyl sterol standards were eluted from the plate and examined further by chromatography on 3% SE-30 columns and GC-MS. Limit of detection is 0.1 mg sterol per leaf sample.
  • H. zea (com earworm) was reared on an artificial diet treated with different sterol supplements to study the relation between sterol structure and utilization in insects. H. zea eggs were used to establish a disease-free stock colony.
  • the stock insects were reared using sterile procedures on a pinto bean-based diet. Moths were fed 10% sucrose. Cultures were maintained at 27 + l°C, at 40 ⁇ 10% relative humidity on a 14:10 light-dark photoperiod and an artificial diet was used to rear the insects on different sterol supplements.
  • the experimental diet contained agar, which is known to contain trace contamination of cholesterol, otherwise the experimental diet was sterol-free.
  • Sterols were solubilized in acetone. Aliquots of the solutions were added to the sterol- free diet in a mortar, the material mixed thoroughly with the diet, and the organic solvent allowed to evaporate. Sterols were supplied to the medium at 200 ppm (equivalent to 1 mg of sterol per experimental vessel containing one insect).
  • H. zea larva are in the final stage of larval development (sixth instar), after which the insects may pupate.
  • a single neonate larva was placed in an experimental culture vial and allowed to grow for 20 days. The fresh weight, length and instar stage of 20-day larva were recorded.
  • the larvae were allowed to grow for another 4 days to determine whether they could pupate properly and develop into moth forms. Neonate larvae of H. zea failed to molt to the second instar when sterol was absent from the diet. Some of these insects survived for more than 15 days.
  • Sterols isolated from the nonsaponifiable lipid fraction extracted from larvae contain long chain fatty alcohols. These fatty alcohols may comigrate with sterols during some forms of chromatography and interfere with sterol quantitation, particularly of cholesterol. Therefore, in order to confirm the identity and amount of cholesterol in the insect an aliquot of the NSF was injected into a HPLC column and the fraction corresponding to cholesterol was examined by GC-MS.
  • Larvae did not develop on a sterol-less medium.
  • These sterols are referred to as "utilizable" sterols (Table 11 and Fig. 9).
  • the major sterol recovered from the larvae was cholesterol, showing that H. zea operates a typical insect 24-dealkylation sterol pathway.
  • Fig. 9 Indicates the structures in Fig. 9.
  • the minimal dietary concentration of cholesterol necessary for larvae to grow and pupate is 0.01 % of the experimental diet. This level of cholesterol does not support a rapid rate of molting as did higher levels of cholesterol. However, diets of 0.015% cholesterol or more enhanced the rate of development of larvae. Therefore, a slightly higher amount of dietary sterol (0.02%) was used to insure that a non-limiting amount of sterol (alone or as a mixture) was available in the experimental diet, or no sterol was added to the diet to act as a control.
  • Table 11 and Fig. 9 show that the position of the double bond in the sterol side chain and nucleus is critical to sterol-controlled growth.
  • the inability of cholest-8-enol to support growth suggests that H. zea cannot transform 9 ⁇ ,19-cyclopropyl sterols to c o
  • compositions and methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. While the compositions and methods of this invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations may be applied without departing from the concept, spirit and scope of the invention. More specifically, it will be apparent that certain agents which are both chemically and physiologically related may be substituted for the agents described herein while the same or similar results would be achieved. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims.
  • ADDRESSEE ARNOLD, WHITE & DURKEE
  • B STREET: P.O. BOX 4433
  • NAME KAMMERER, PATRICIA A.
  • Tyr Lys Ala Gly lie Gin Arg Gly Asp Leu Val Leu Asp Val Gly Cys 115 120 125
  • Ala lie Glu Ala Thr Cys His Ala Pro Lys Leu Glu Gly Val Tyr Ser 195 200 205
  • Glu lie Tyr Lys Val Leu Lys Pro Gly Gly Thr Phe Ala Val Tyr Glu 210 215 220 Trp Val Met Thr Asp Lys Tyr Asp Glu Asn Asn Pro Glu His Arg Lys 225 230 235 240 lie Ala Tyr Glu lie Glu Leu Gly Asp Gly lie Pro Lys Met Phe His 245 250 255
  • GAAACATCAC CGGAAAAAGT ATGGAGAATT TTCTCAATTT GTTTTTATTT TTAAGTTAAA 1200 TCAACTTGGT TATTGTACTA TTTTTGTGTT TTAATTTGGT TTGTGTTTCA AGAATTATTA 1260
  • CTAGCTTCTA TGAGTATGGT TGGGGTGAAT CCTTCCACTT TGCTCACAGA TGGAATGGAG 300 AATCCTTACG TGAAAGCATC AAGCGACATG AGCATTTTCT TGCCCTGCAA CTTGGTTTGA 360
  • CAAGATTTAG CTCAACTTCA GTTACCGGAT TGAATAACCA
  • GAAAGGAGCT CAACCGTTTA GCAGGAATTA GTGGAACATG TGATTTTGTC AAGGCGGACT 540

Abstract

Plant phytosterol compositions are modulated in transgenic plants to confer resistance to insects, nematodes, fungi, and/or other environmental stresses, and/or to improve the nutritional value of the plants. Recombinant DNA molecules of the invention encode RNA or protein sequences capable of altering plant sterol profiles by affecting the expression or activity of sterol biosynthetic enzymes. The DNA molecules are transformed into plant cells and plants having altered sterol compositions are regenerated therefrom.

Description

TRANSGENIC PLANTS WITH MODIFIED STEROL BIOS YNTOETIC PATHWAYS
FIELD OF THE INVENTION
The present invention broadly relates to plant genetic engineering. More particularly, it concerns the manipulation of the levels and/or activities of endogenous plant phytosterol compositions as a strategy for minimizing crop damage due to plant insects and other pests, and/or for improving the nutritional value of plants.
BACKGROUND OF THE INVENTION Productivity in agricultural industries can be adversely affected by various environmental stresses, including drought, severe cold, weeds, and organisms that feed on crops. Conventional approaches for alleviating weeds and parasitic organisms have relied almost exclusively on chemical herbicides, pesticides and fungicides. Widespread use of these agrochemicals, however, has led to development of resistance. In fact, insect resistance has been reported against most major classes of insecticides including organophosphates, chlorinated hydrocarbons, and carbamates.
Sterols comprise a class of essential natural compounds required to some extent by all eukaryotic organisms. They have a common tetracyclic steroid nucleus and a side chain, as shown in the diagram below. Some sterols serve a structural role in cell membranes, while others are required during development.
Plants produce more than 250 different phytosterols (Akisha et al., 1992). As many as 60 sterols have been identified in the single species, Zea mays (corn) (Guo et al., 1995). However, insects, fungi and nematodes, as well as many other sterol-less parasitic organisms, do not synthesize all of their necessary sterols de novo. Rather, they satisfy their nutritional requirements for sterols by feeding on plants. This fact has been utilized in the development of commercial agrochemicals such as triazoles, pyrimidines and azasterols, which act by interfering with production of sterols within parasitic organisms.
Figure imgf000004_0001
Recent advances in molecular biology have made it possible to introduce advantageous traits into plants via genetic engineering. Some forms of insect resistance have been introduced into plants by genetic approaches. For example, transgenic plants expressing foreign genes encoding endotoxins of Bacillus thuringiensis (Bt) can confer on the plants the ability to kill pests which feed on them. Unfortunately, approaches such as this are effective only against the particular insects susceptible to the endotoxin. There remains in the agricultural industries a continual need for alternative pest control strategies, particularly those that could be broadly effective against numerous pests/pathogens. SUMMARY OF THE INVENTION
"The present invention broadly relates to approaches for genetically engineering plants to have altered sterol compositions, levels and/or metabolism. Such approaches can increase the plants natural insect resistance, can increase the plants resistance to drought and cold, and/or can improve the nutritional/health value of the plants.
In accordance with one aspect of the invention, there are provided recombinant DNA molecules comprising: a promoter which functions in plants to cause the production of an RNA sequence, operably linked to a DNA coding sequence encoding an enzyme which binds a first sterol and produces a second sterol, operably linked to a 3' non-translated region which causes the polyadenylation of the 3' end of the RNA sequence; wherein the promoter is heterologous with respect to the DNA sequence.
The DNA coding sequence encoding an enzyme which binds a first sterol and produces a second sterol can be in the sense or antisense orientation. Thus, the DNA molecule of the invention can encode a non-translatable RNA molecule (e.g., antisense or cosuppression) or a protein molecule. The RNA or protein so produced selectively targets the expression and/or activity of a sterol biosynthetic enzyme to affect a desired change in the phytosterol profile of the plant.
Therefore, in accordance with another aspect of the present invention, there is provided an approach for modifying the sterol composition of plants to increase their resistance to insects, nematodes, and pythiaceous fungi. This aspect of the invention enhances the plant's ability to resist pests and disease by modifying the composition and/or distribution profile of certain phytosterols. Such an approach overcomes many of the limitations inherent in the use of agrochemicals, or with transgenic plants where the foreign product introduced into the plant has the potential to eventually select for new mechanisms of resistance by the pest. The present invention retains the benefits obtained through the use of agrochemicals, but avoids many of their disadvantages. By targeting an existing essential pathway in pests and pathogens, this invention reduces the likelihood of the evolution of mechanisms which circumvent this pathway.
Plant sterol composition is modified in this aspect by increasing the amount of non- utilizable sterols such as 4-methyl sterol, 9β,19-cyclopropyl sterol, Δ7-sterol, Δ8-sterol, 14α-methyl sterol, Δ23(24)-24-alkyl sterol, Δ24(25),24-alkyl sterol or Δ25(27),24-alkyl sterol. Alternatively, sterol compositions can be modified to contain lower levels of sterols having a Δ5 group.
Another aspect of the present invention relates to producing sterols in plants that confer resistance to drought and cold in plants.
Another aspect of the invention relates to altering the sterol profile of plants such that levels of cholesterol-lowering sterols are increased.
The aspects of the invention described herein are typically achieved by modifying the expression and/or activities of sterolic enzymes, preferably S-adenosyl-L-methionine- Δ24-sterol methyl transferases (SMTT and SMTπ), C-4 demethylase, cycloeucalenol to obtusifoliol-isomerase, 14α-methyl demethylase, Δ8 to Δ7-isomerase, Δ7-sterol-C-5- desaturase, or 24,25-reductase.
Another aspect of the invention is directed to transgenic plants having altered levels of selected sterols, produced by introducing recombinant DNA molecules of the invention into the genome of plant cells and selecting for cells expressing said molecule. Transgenic plants are regenerated from the transformed plant cells and plants containing the recombinant DNA are grown to maturity. Plants expressing the recombinant DNA are identified and those having a desired sterol profile in accordance with the present invention are selected and propagated. BRIEF DESCRIPTION OF THE DRAWINGS
"The following drawings form part of the present specification and are included to further demonstrate certain aspects of the present invention. The invention may be better understood by reference to one or more of these drawings in combination with the detailed description of specific embodiments presented herein.
Fig. 1 shows HPLC radiocount (panel B) and mass spectrum (panel A) results of testing SMT enzyme with radiolabeled substrate co-factor;
Fig. 2 shows six inhibitors used to test the SMT enzyme;
Fig. 3 shows SMT activity during seedling development;
Fig. 4 shows the pathway of sterol end-products during development of seedlings;
Fig. 5 shows the yeast SMT gene sequence (panel B; SEQ ID NO:l) and the deduced amino acid sequence (panel A; SEQ ID NO: 2) with the predicted conserved regions highlighted;
Fig. 6 shows the Arabidopsis SMT gene (panel B; SEQ ID NO: 3) and deduced amino acid (panel A; SEQ ID NO: 4) sequences;
Fig. 7 shows the ERG6 constructs prepared with pUC18cpexp expression cassette;
Fig. 8 shows sequences of yeast SMT gene (SEQ ID NO: 5). Underlined sequences are those used as primers for screening genomic DNA from transgenic tomato plants; and
Fig. 9 shows structures of plant sterols tested on Heliothis zea and found to be utilizable or non-utilizable. Figure 10 (SEQ ID NO: 6) shows the nucleotide and amino acid sequences of the corn SMT gene.
DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
PHYTOSTEROLS
The phytosterol metabolic pathway consists of enzymes that act on the tetracyclic ring nucleus and the side chain. The major pathway in advanced vascular plants starts from cycloartenol (I):
Figure imgf000008_0001
and ends with Δ -24-alkyl sterols, predominantly sitosterol (II), stigmasterol (III) and campesterol (IV):
Figure imgf000008_0002
Figure imgf000009_0001
Figure imgf000009_0002
The number of alternate pathways is sufficiently great to produce as many as 60 or more different sterols in a single plant. These alternate pathways vary according to tissue- and development-specific genetic programs.
Studies of sterol metabolism have utilized inhibitors of sterol biosynthesis. These inhibitors include several commercial fungicides which block sterol metabolic pathways in plant pathogenic fungi and thereby inhibit their growth. The following steps of the major metabolic pathway were determined using metabolic inhibitors. The major pathway consists of the 12 chemical transformations as follows. In reaction 1 , the enzyme S-adenosyl-L-methionine-sterol-C-24 methyl transferase -(SMTj) catalyzes the transfer of a methyl group from a cofactor, S-adenosyl-L- methionine, to the C-24 center of the sterol side chain. The circled sterol feature is the functional group undergoing transformation.
Figure imgf000010_0001
Cycloartenol
24(28)-Methylenecycloartanol
This is the first of two methyl transfer reactions, and is an obligatory and rate-limiting step of the sterol-producing pathway in plants. A different SMT enzyme, SMTπ, catalyzes the conversion of cycloartenol to a Δ 23(24) 24-alkyl sterol, cyclosadol (Guo et al., 1996).
Reaction 2 involves a demethylation at C-4. This is the first of several demethylation reactions in the nucleus.
Figure imgf000010_0002
Cycloeucalenol
24(28)-Methylenecycloartanol Reaction 3 involves opening the cyclopropyl ring at C-9(10) by the enzyme cycloeucalenol-obtusifoliol isomerase (COI), which also creates a double bond at C-8.
Figure imgf000011_0001
Cycloeucalenol
Obtusifoliol
Reaction 4 involves a demethylation at C-14 which removes the methyl group at C-14 and creates a double bond at C-14.
Figure imgf000011_0002
4α-Methyl-5α-ergosta-
Obtusifoliol 8,24(28)-trien-β-ol
Reaction 5 is catalyzed by a Δ 14 reductase.
Figure imgf000011_0003
4α-Methyl-5α-ergosta- 4α-Methyl-5α-ergosta- 8,24(28)-trien-β-ol "9" 8,24(28)-dien β-ol Reaction 6 involves a Δ8- to Δ7-isomerase reaction which produces a Δ7 group.
Figure imgf000012_0001
4α-Methyl-5α-ergosta- 8,24(28)-dien-3β-ol
24-Methylenelophenol
Reaction 7 is a second C- methylation of the sterol side chain. The reaction is catalyzed by SMTj, the same enzyme that initiated the major pathway.
Figure imgf000012_0002
24-Methylenelophenol 24-Ethylidenelophenol
(citrastadienol)
Reaction 8 involves a C-4 demethylase to generate a 4,4-desmethyl sterol.
Figure imgf000012_0003
Avenasterol
Figure imgf000012_0004
24-Ethylidenelophenol
-10- (citrastadienol) Reaction 9 involves a Δ desaturase, producing a double bond at C-5 in the tetracyclic ring.
Figure imgf000013_0001
Stigmasta-5, 7,24(24')-
Avenasterol trien-3β-ol
The product of reaction 9 is then transformed in reaction 10 by a Δ7-reductase by removing the double bond at C-7.
Figure imgf000013_0002
Isofucosterol
Stigmasta-5,7,24(24') trien-3β-ol
15
Reaction 11. involves a Δ24(28)- to Δ24(25)-isomerase which modifies the side chain. (It is believed that this reaction would have proceeded from the product of reaction 5 if the kinetics were more favorable.)
Figure imgf000014_0001
Stigmasta-5 ,24-dienol
Isofucosterol
Reaction 12: the Δ24(25) double bond at C-24 is reduced stereoselectively to produce sitosterol (II).
Figure imgf000014_0002
Stigmasta-5 ,24-dienol
Sitosterol
In addition to this major pathway of sterol biosynthesis, it has been found that a developmental program regulates expression of the SMT enzymes. In corn, enzymology studies have shown that two different SMT enzymes exist (SMTT and SMTπ) whose expression depends on the tissue and stage of differentiation. Blades mainly contain 24- ethyl sterols (resulting from the activity of SMTT), whereas the sheaths contain mainly 24-methyl sterols (VI) (resulting from the activity of SMTπ). These sterols are the products of the two different SMT enzymes that react with the same starting material, cycloartenol.
The first enzyme, SMTi, produces Δ24(28)-methylene and the second enzyme produces Δ -methyl sterol (V). The first isoform leads to a utilizable sterol (a sterol which can be utilized by insects, pythiaceous fungi, and nematodes to complete their life cycles). The second isoform produces a non-utilizable sterol (a sterol which cannot be utilized by insects, pythiaceous fungi, and nematodes to complete their life cycles). Therefore, one could inhibit expression of the first isoform so as to cause accumulation of the non- utilizable Δ23(24)-methyl sterols.
Figure imgf000015_0001
Cyclosadol 15
As a result, the sterols that accumulate in the tissue contain a double bond at C-23 (VI) and a methyl at C-24.
Figure imgf000015_0002
24-methyl cholesta-5,23-dienol RECOMBINANT DNA MOLECULES:
In order to achieve a desired alteration in sterol composition, the invention provides recombinant DNA molecules for use in the production of transgenic plants. A recombinant DNA molecule of the invention generally comprises a promoter region capable of causing the production of an RNA sequence in plants, a structural DNA sequence, and a 3' non-translated region.
Transcription of DNA into mRNA is regulated by the region of a gene referred to as the "promoter". The promoter region contains a sequence of bases that signals RNA polymerase to associate with the sense and antisense DNA strands and to use the sense strand as a template to make a corresponding strand of mRNA complimentary to the sense DNA strand. This process of mRNA production using a DNA template is commonly referred to as gene "expression" or "transcription" .
In the recombinant DNA molecules of the invention, it is generally preferred that the promoter is heterologous with respect to the DNA coding sequence. The term "heterologous" with respect to a promoter means that the DNA coding sequence of a recombinant DNA molecule of the invention is not derived from the same gene to which the promoter is attached.
Promoters may be obtained from a variety of sources, such as plants and plant viruses. The particular promoters selected for use in embodiments of the present invention should preferably be capable of causing the production of sufficient expression to affect the desired change in the sterol distribution profile of the plant.
A number of promoters which are active in plant cells have been described in the literature, and are suitable for use in the DNA molecules of this invention. These include, for example, the cauliflower mosaic virus (CaMV) 35S promoter (Odell et al. 1985), the Figwort mosaic virus (FMV) 35S (Sanger et al. 1990), the sugarcane baciUiform virus promoter (Bouhida et al., 1993), the commelina yellow mottle virus promoter (Medberry and Olsewski 1993), the light-inducible promoter from the small ■subunit of the ribulose-l,5-bis-phosphate carboxylase (ssRUBISCO) (Coruzzi et al., 1984), the rice cytosolic triosephosphate isomerase (TPI) promoter (Xu et al. 1994), the adenine phosphoribosyltransferase (APRT) promoter of Arabidopsis (Moffatt et al. 1994), the rice actin 1 gene promoter (Zhong et al. 1996), the mannopine synthase and octopine synthase promoters (Ni et al. 1995). All of these promoters have been used to create various types of DNA constructs which have been expressed in plants.
Recombinant DNA molecules also typically contain a 5' non-translated leader sequence. This sequence can be derived from the promoter selected to express the gene, and if desired, can be specifically modified so as to increase translation of the mRNA. The 5' non-translated regions can also be obtained from viral RNAs, from suitable eukaryotic genes, or from synthetic gene sequences.
The structural DNA sequence of the recombinant DNA molecule of the invention will cause the desired alteration in the sterol profile of the plant, as discussed further below.
The 3' non-translated region of a recombinant DNA molecule of the invention can be obtained from various genes which are expressed in plant cells. For example, the nopaline synthase 3' untranslated region (Fraley et al. 1983), the 3' untranslated region from pea ssRUBISCO (Coruzzi et al. 1994), and the 3' untranslated region from soybean 7S seed storage protein gene (Schuler et al. 1982) are frequently used. The 3' non-translated region of a recombinant DNA molecules contains a polyadenylation signal which functions in plants to cause the addition of adenylate nucleotides to the 3' end of the RNA.
Other desired regulatory sequences known to the skilled individual, or combinations thereof, can be included in a recombinant DNA molecule of the invention. For example, intron sequences are frequently included in recombinant DNA molecules used for producing transgenic plants in order to enhance expression levels. Examples of plant introns suitable for expression in plants can include maize hsp70 intron, rice actin 4 intron, maize ADH 1 intron, Arabidopsis SSU intron, Arabidopsis EPSPS intron, petunia EPSPS intron and others known to those skilled in the art.
PLANT TRANSFORMATION AND REGENERATION
A double stranded DNA molecule of the present invention can be inserted into the genome of a plant by any suitable method. Numerous plant transformation methods have been described, including Agrobacterium-mediated transformation, the use of liposomes, electroporation, chemicals that increase free DNA uptake, free DNA delivery via microprojectile bombardment, transformation using viruses or pollen, etc.
After transformation of cells (or protoplasts), choice of methodology for the regeneration step is not critical, with suitable protocols being available for hosts from Leguminosae (alfalfa, soybean, clover, etc.), Umbelliferae (carrot, celery, parsnip), Cruciferae (cabbage, radish, rapeseed, etc.), Cucurbitaceae (melons and cucumber), Graminae (wheat, rice, com, etc.), and Solanaceae (potato, tobacco, tomato, peppers). Methods for transformation and regeneration of dicots, primarily by use of Agrobacterium tumefaciens, and obtaining transgenic plants, have been described for numerous plant species, including cotton (U.S. Patent No. 5,004,863; U.S. Patent No. 5,159,135; U.S. Patent No. 5,518,908), soybean (U.S. Patent No. 5,569,834; U.S. Patent No. 5,416,011; Christou et al. (1988)), Brassica (U.S. Patent No. 5,463,174), peanut (Cheng et al. (1996); papaya (Yang et al. (1996), and pea (Schroeder et al. (1993); De Kathen and Jacobsen (1990)), and others.
Transformation of monocots using electroporation, particle bombardment, and Agrobacterium have also been reported. Transformation and plant regeneration have been achieved, for example, in asparagus (Bytebier et. (1987)), barley (Wan and Lemaux (1994)), maize (Rhodes et al. (1988); Gordon-Kamm et al. (1990); Fromm et al. (1990); Koziel et al. (1993); Armstrong et al. (1995)), oat (Somers et al. (1992)), orchardgrass (Horn et al. (1988)), rice (Toriyama et al. (1988); Battraw and Hall (1990); Christou et al. (1991)), rye (Bryant (1987)), sugar cane (Bower and Birch (1992)), tall fescue (Wang et al. (1992)), and wheat (Vasil et al. (1992); Weeks et al. (1993)).
For reviews of plant transformation and/or regeneration methodologies see, for example, Ritchie and Hodges (1993) or Hinchee et al. (1994).
INSECT/PEST RESISTANCE VIA PHYTOSTEROL ALTERATIONS
A series of phytosterols were tested in insects and many were found to be unable to support insect growth, i.e., were non-utilizable. These sterols included 9,19- cyclopropyl sterols. Furthermore, novel Δ(23(24)- and Δ24(25)-alkene and Δ25(27)-alkyl sterols were also determined to be unable to support insect growth and maturation. These were tested in vivo using Heliothis zea (a corn earworm), cultured on synthetic media that was sterol-free with the exception of added test sterols. It was found that if the ratio of utilizable to nonutilizable sterols was 1:9 or less, insects could not undergo normal develop. In fact, even at 1:1 ratios, insect development was adversely affected.
The metabolism of insects, nematodes and pythiaceous fungi is limited by the availability of major plant sterols. These pests cannot use a sterol with a C-4 methyl group; a 9β, 19-cyclopropyl group, or a Δ group. Furthermore, nematodes and insects cannot utilize 14-α methyl-sterols, and some insects, including lepidoptera, diptera and coleoptera, cannot utilize C-24 alkyl sterols with Δ24(25), Δ23(24), or Δ25(27) groups for mechanistic reasons. Some insects cannot utilize sterols lacking a Δ5 group. Consequently, elevation of these sterols in plants would provide a detrimental dietary source of sterols for these pests.
The DNA molecule of the present invention, when expressed in transgemc plants, will cause alterations in the composition/distribution of the sterols present in the plant. In one preferred embodiment, the DNA molecule causes the accumulation of sterols that are non-utilizable by insects and other pests, so as to increase the plants resistance to the organisms. This can be accomplished, for example, by a number of approaches, including overexpression, antisense, cosuppression etc. The DNA molecule of the invention will typically target an endogenous gene encoding an enzyme selected from the kinetically favored pathways of sterol biosynthesis.
In this embodiment, it is preferred that gene expression and/or translation of a sterol biosynthetic enzyme is targeted for inhibition. This inhibition can be achieved, for example, by engineering a DNA molecule of the invention to produce an antisense, ribozyme or cosuppression RNA molecule complementary to an endogenous gene being targeted. Approaches for the targeted inhibition of gene expression are well known to the skilled individual (for reviews, see Bird et al., 1991; Schuch, 1991; Gibson et al., 1997)
A preferred target for inhibition is the S-adenosyl-L-methionine-Δ24(25)-sterol methyl transferase (SMT) enzyme. By targeting this gene with an antisense or cosuppression construct, expression of SMT can be effectively suppressed, thereby causing the accumulation of non-utilizable sterols.
Besides SMT, other genes in the phytosterol transformation pathway can also be targeted in this and other embodiments of the invention in order to alter the profile of sterols in transgenic plants. The preferred target will depend on the application, however the approach is the same, i.e., to express an RNA or protein molecule capable of modifying the sterol composition of the plant in a desirable manner.
Therefore, in addition to SMT, other preferred cellular targets for causing sterol modifications include:
(i) C-4 demethylase: This enzyme is involved in the removal of the two methyl groups at C-4 and represents reactions 2 and 8 in the description section. A single protein is responsible for both the reactions. Blocking this enzyme will lead to accumulation of 4,4-dimethyl sterols such as cycloartenol, 24(28)-methylene eycloartenol or a novel sterol such as 24-dihydrolanosterol (structure 18 in Fig. 9). All these are nonutilizable sterols. This may be achieved through suppression of this gene in plants.
(ii) Cycloeucalenol to obtusifoliol isomerase (COI) and Δ "to-Δ isomerase: These enzymes represent reactions 3 and 6 in the pathway. Certain fungicides are known to block these two enzymes in plants leading to the accumulation of 9β,19-cyclopropyl sterols. Locusts reared on these treated plants are known to have abnormal development and levels of cholesterol and ecdy steroids in these insects are depleted. This suggests that if either of these enzymes are disrupted or suppressed, the plant sterols can be altered such that they will not support insect development (Coste et al., 1987).
(iii) C-14 demethylase: This is reaction 4 in the pathway. There are several fungicides and plant growth regulators that block this step in fungi and plants. In plants this blockage leads to a depletion of the normal Δ5-sterols and an accumulation of 9β,19-cyclopropyl, 14α-methyl and Δ8-sterols that are intermediates of the main phytosterol pathway. These are also non-utilizable sterols. Studies with chemical inhibitors have also shown that plants accumulating these intermediates are tolerant to water and cold stress. Thus, suppression of this enzyme activity through gene manipulation is also a useful strategy.
(iv) Δ7-sterol-C-5-desaturase: This is reaction 9 in the pathway. Inhibition of this enzyme leads to a depletion of Δ5-sterols and an increase in Δ7-sterols. Certain insects are known to be unable to metabolize Δ7-sterols into ecdy steroids. Therefore, accumulation of Δ -sterols in plants can also provide a way to form non-utilizable sterols. Further, Δ7-sterols can replace Δ5-sterols in plant membranes without any morphological changes in plant development. (v) C-24 reductase: This is the terminal step in phytosterol transformation (reaction -12) during the formation of sitosterol, the major Δ5-sterol in plants. Disruption or suppression of the gene encoding this enzyme would result in the accumulation of Δ24(25)-24-alkyl sterols which are also non-utilizable.
Many of the genes encoding these preferred sterol biosynthetic enzymes to be targeted by the present invention have been isolated from yeast (for review, see Lees et al., 1997). Some have been isolated from plants. For example, SMT genes have been isolated from soybean (Shi et al., 1996), arabidopsis (Husselstein et al., 1996; Bouvier- Nave et al., 1997) tobacco and castor (Bouvier-Nave et al., 1997); and corn (Grabenok et al., 1997). Other plant sterol biosynthetic genes that have been isolated include delta7-sterol-C5-desaturase from arabidopsis (Gachotte et al., 1996) and cycloartenol synthase from arabidopsis (Corey et al., 1993).
Where not available, the gene encoding a sterol biosynthetic enzyme can be readily isolated from a desired source by approaches known to the skilled individual. For example, an isolated gene or cDNA from one source can be used as a hybridization probe for the isolation of homolgous sequences from other sources. However, it should be noted that a DNA molecule of the invention should be active in numerous plant types, regardless of the source of the sterol biosynthetic gene used in the targeting construct, given the successful demonstration provided herein of using a yeast ERG6 antisense construct to alter the sterol profile in tomato.
Preferably, the following sterolic metabolic enzymes are targeted for inhibition: S- adenosyl-L-methionine-Δ24-sterol methyl transferase, C-4 demethylase, cycloeucalenol to obtusifoliol-isomerase, 14α-methyl demethylase, Δ8- to Δ7-isomerase, Δ7-sterol-C-5- desaturase, or a 24,25-reductase.
Plants produced according to this embodiment preferably have increased amounts of certain sterols that are non-utilizable, particularly 4-methyl sterol, 9β,19-cyclopropyl sterol, Δ8-sterol, Δ7-sterol, 14α-methyl sterol, Δ23(24),24-alkyl sterol, Δ24(25)-24-alkyl •sterol or Δ25(27)-24-alkyl sterol, or decreased levels of sterols having a Δ5 group.
Preferred crops for use in providing insect resistance according to this embodiment of the invention include com (European com borer, com earworm, fall armyworm), rice, sorghum, forestry, potato, tomato (tomato hornworm), and vegetable brassicas. Preferred crops for use in providing nematode resistance according to this embodiment of the invention include soybean (soybean cyst nematode), tomato (root knot nematode), sugarbeet and cucurbits.
Preferred crops for use in providing fungal resistance according to this embodiment of the invention include corn, rice, wheat, surghum, soybean (Phytophthora root rot), sunflower, forestry, fruits and berries, potato (late blight), tomato (late blight), sugarbeet, cucurbits, and vegetable brassicas.
PHYTOSTEROLS AS CHOLESTEROL-LOWERING AGENTS
Animal and human studies have demonstrated that phytosterols can reduce serum and/or plasma total cholesterol and low density lipoprotein (LDL) cholesterol (Ling and Jones, 1995). In this regard, transgenic plants having altered sterol profiles could be instrumental in establishing a dietary approach to cholesterol management and cardiovascular disease prevention.
Structure-specific effects of individual phytosterols have recently been shown where saturated phytosterols, such as sitostanol, are more efficient compared to unsaturated compounds such as sitosterol in reducing cholesterol levels. Another structural feature that seems to play a role is esterification of the phytosterols. Some studies suggest that the ferrulate esters of sitosterol, sitostanol or cycloartenol have a more potent effect on lowering serum cholesterol than the corresponding free sterols (Meittinen and Vanhanen, 1994). Some of the natural sources of phytosterols in the diet are rice bran oil, corn fiber oil and •soybean oil. Rice bran and corn fiber are by far the most enriched sources of phytosterols. Soybean phytosterols are a byproduct of the oil refining process. Technologies that can generate higher levels of these nutritionally useful phytosterols in these and other plants will assist in the development of new food products to improve human health and wellness.
Therefore, the present invention, in another embodiment, relates to increasing cholesterol- lowering sterols in transgenic plants. For example, with a recombinant DNA molecule of the invention, the conversion of cycloartenol in developing seeds can be inhibited, for example by antisense, cosuppression, or ribozyme-mediated inhibition of SMT expression, thereby leading to an accumulation of this sterol in seed oils. Alternatively, the SMT gene can be overexpressed in order to increase the levels of sitosterol.
Preferred crops for use in accordance with this embodiment of the invention include sunflower, corn, soybean, oilseed brassicas and cotton.
STRESS TOLERANCE THROUGH ALTERATIONS IN PHYTOSTEROLS
Another embodiment of this invention derives from the fact that certain sterols are associated with reducing water permeability of membranes. For this reason, sterol manipulation should provide an effective means for preventing or at least minimizing drought induced damage.
Several studies with chemical inhibitors of sterol biosynthesis have documented that the treated plants show secondary physiological responses that include tolerance to environmental stresses such as drought and frost (Fletcher, 1988). Such responses are primarily due to elevated levels of hormones such as abscisic acid. However, changes in membrane fluidity have also been recognized as being responsible for stress tolerance (Steponkus, 1984). Membrane fluidity is controlled by several factors such as the type of sterols and fatty acids and the ratio between fatty acids and sterols in the membranes. Of these factors, the type of sterols is by far the most important factor. A principal function of the sterols is to buffer membranes against abrupt changes in fluidity. They also may have more specific influences on the activity of membrane-bound enzymes. An impairment of sterol biosynthesis, through the application of inhibitors, resulting in depletion of terminal sterols and accumulation of intermediates might therefore be expected to alter membrane function.
There is evidence to show that inhibition of sterol biosynthesis in plants leads to elevated levels of abscisic acid and closure of stomata (Haeuser, C. et al 1990 J. Plant Physiol. 137: 201-207). How this process is mediated is not clear. But what is well documented is that modification of phytosterols can lead to some forms of stress tolerance, which is most likely mediated by elevated levels of abscisic acid. Further, in all these studies with chemical inhibitors of sterol biosynthesis, the accumulating sterols are those recognized in this invention as nonutilizable. These are again, 9β,19-cyclopropyl sterols, 14α-methyl sterols and Δ8-sterols. Thus, formation of nonutilizable sterols in plants through the various gene manipulation strategies described in this invention will not only protect the plants from pests and pathogens but also from environmental stresses such as drought and cold. Preferred sterols to be elevated in this aspect include Δ5-24 alkyl sterols, such as 24-methyl cholesta-5,23-dienol, and cycloartenol.
Preferred crops for use in accordance with this embodiment of the invention include com, wheat, rice, sorghum, soybean, oilseed brassicas (rapeseed, canola), sunflower, palm, peanut, cotton, forestry, fruits, berries, nuts, potato, tomato, sugarbeet, sugarcane, cucurbits (squash, melons, cucumbers, watermelons, pumpkins), vegetable brassicas, alfalfa, ornamental crops, turfgrass, peanut, tea and coffee.
The following examples are included to demonstrate preferred embodiments of the invention. It should be appreciated by those of skill in the art that the techniques disclosed in the examples which follow represent techniques discovered by the inventor •to function well in the practice of the invention, and thus can be considered to constitute preferred modes for its practice. However, those of skill in the art should, in light of the present disclosure, appreciate that many changes can be made in the specific embodiments which are disclosed and still obtain a like or similar result without departing from the spirit and scope of the invention. Unless specifically indicated, all techniques discussed in the description above and used in the examples which follow can be performed by standard molecular biological and biochemical methodologies well known to the skilled individual (as described, for example, in Sambrook et al., 1989).
EXAMPLES
Example 1. Plant Phytosterols
Sterol isomers were extracted from corn and were isolated to homogeneity using chromatographic methods. Novel phytosterols were identified with side chains that have been found to be non-utilizable in insects.
The sterols were structurally characterized by mass spectroscopy and 1H and 13C nuclear magnetic resonance (NMR) (Table 1) (Guo et al, 1995).
The initial studies showed that 4-day corn shoots could produce mono- and di-alkylated sterols at C-24. Com could produce those sterols, since isolated 24(28)-methylene and 24(28)ethylidene sterols were obtained from seedling tissue of com and their structures were confirmed by mass and proton nuclear magnetic resonance spectroscopy.
Table 1
Sterol Composition of Zea mays
Sterol M MMSSaa TTLLCCa Plant Source0
(M+) (Rf)
Cycloartenol 426 0.29 st, c, g, r, sh, b, p Sterol M MSa TLCa Plant Source0
(M+) (Rf)
24(28)-Methylene-cycloartanol 440 0.29 st, c, g, r, sh, b, p
Cyclosadol 440 0.29 st, g, sh
Cyclolaudenol 440 0.29 st
Cycloartanol 428 0.29 sh
24-Methylcycloartanol 442 0.29 g
24(28)-Methyleneparkeol* 440 0.29 sh α-Amyrin (triterpene) 426 0.29 st, c, g, r, sh, b β-Amyrin (triterpene) 426 0.29 st, c, g, r, sh, b
4α, 14α-Dimethylergosta-7,24(28)- 424 0.25 st, c, g, r, sh, b dienol
Lophenol 400 0.25 g, sh
24-Methylene-lophenol 412 0.25 c, g, r, sh, b, p, I
24-Methyl-lophenol 414 0.25 g, sh
24-Ethyl-lophenol 428 0.25 g
Cycloeucalenol 426 0.25 c, g, r, sh
Obtusifoliol 426 0.25 c, g, r, sh, b, p
Dihydroobtusifoliol 428 0.25 sh
31-Norlanosterol 412 0.25 sh
4α-Methylergosta-8,24(28)-dienol* 412 0.25 b
4α-Methylergosta-7(E)-23-dienol 412 0.25 c, g, sh
4α-Methylergosta-7(Z)-23-dienol* 412 0.25 sh
Citrastadienol 426 0.25 c, g, r, sh, b
Isocitrastadienol 426 0.25 sh
4α, 14α-Dimethyl-ergosta-8(E)-23- 426 0.25 c, sh dienol
4α, 14α-Dimethyl-ergosta-8(Z)-23- 426 0.25 sh dienol
4α,14α-Dimethyl-24-ethyl-cholest-8- 442 0.25 sh enol
4α, 14α-Dimethyl-9, 19-cycloergost- 426 0.25 c, sh 23-enol
4α-Methyl-cholesta- 410 0.25 sh 8(9),14(15),24(28)-trienol*
Cholesta-5 ,22-dienol* 384 0.18 sh
Cholest-7-enol 386 0.16 b
Cholest-8(9)-enol* 386 0.18 b Sterol M MSa TLCa Plant Source0
(M+) (Rf)
Cholesterol 386 0.18 st, c, g, sh, b, p
Cholestanol 388 0.16 st
Brassicasterol 398 0.18 st, sh
24-Methylene-cholesterol 398 0.18 st, c, g, sh, b, r, t, p
Ergosta-5(E)-23-dienol 398 0.18 st, c, g, sh, b, r
Codisterol 398 0.18 st, sh
Ergosta-7(E)-23-dienol 398 0.16 st, c, sh
24-Methylene-cholest-7-enol 398 0.16 st, c, sh, p
24-Methylene-zymosterol 398 0.18 P
Campesterol 400 0.18 st, c, g, sh, b, r, t, p
24-Epicampesterol 400 0.18 st, c, g, sh, b, r, p
**
Ergost-(E)-23-enol 400 0.16 sh
14α-Methyl-cholest-7-enol 400 0.16 sh
Ergost-7-enol 400 0.16 st, c
Ergost-8(9)-enol* 400 0.18 sh
Ergostanol 402 0.16 st, c, sh
24β-Ethylcholesta-5 ,22 ,25-trienol 410 0.18 sh
14α-Methylergosta-8,25-dienol 412 0.18 sh
14α-Methylergosta-8,24(28)-dienol* 412 0.18 sh
Stigmasta-7,25-dienol 412 0.16 sh
Stigmasta-8 , 25 -dienol* 412 0.18 sh
24β-ethyl-cholesta-5 ,25-dienol 412 0.18 st, sh
Stigmasta-5 ,23-dienol 412 0.18 sh
Fucosterol 412 0.18 st, g, sh
Isofucosterol 412 0.18 st, c, g, sh, b, r, t, p
24-Ethylcholesta-5 ,24(25)-dienol 412 0.18 st, sh
Avensterol 412 0.16 st, c, sh
25-Methyl-24-methylene-cholesterol 412 0.18 sh
Stigmasterol 412 0.18 st, c, g, sh, b, r, t, p
Stigmast-7-enol 412 0.16 c
Stigmast-22-enol 414 0.16 st, sh
14α-methylergost-8(9)-enol 414 0.18 sh
Sitosterol 414 0.18 st, c, g, sh, b, r, t, p
Stigmastanol 416 0.16 st, sh
MS, mass spectrometry; TLC , think- layer chromatography Sterol M MSa TLCa Plant Source0
(M+) (Rf) new com sterol; new natural sterol st, shoot; c, cloeoptile; g, germ oil; sh, sheath; b, blade; r, root; i, inflorescence; t, tassel; p, pollen
Either trivial or systematic name is given
Biosynthesis of the sterols was analyzed to determine sterol precursor-product relationships. Developmental regulation of sterol metabolism was examined by comparison of different com tissues. The results show sterols in blades contain mainly 24-ethyl sterols, e.g., sitosterol, while sheaths contained mainly 24-methyl sterols, e.g., 24-methyl-cholesta-5 ,23-dienol .
Feeding-trapping experiments with four [3 -3H] 24-methyl sterol isomers incubated with 8-day etiolated sheath tissues indicated that Δ24(28) -methylene and Δ24(25)-24-methyl sterols were precursors of 24α- and 24β-methyl sterols, whereas Δ23(24)-24-methyl and Δ25(27)-methyl sterols were end products of the sterol pathway.
The results showed that a single SMTT enzyme is responsible for the catalysis of two methylation steps and that a critical slow step between cycloartenol (start of pathway) and Δ5-24-alkyl phytosterol (end of pathway) production is the methylation step, which is subject to feed back regulation from 24-ethyl sterols. The SMT! enzyme regulates the type and amount of phytosterols produced from cycloartenol during plant growth and maturation. This finding contradicts the generally accepted view of the role of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR). This enzymatic step occurs very early in the isoprenoid pathway from which sterols are derived and has been considered as the rate-limiting step in phytosterol biosynthesis. The present finding shows that HMGR's role is limited merely to controlling carbon flow into the sterol pathway. Expression studies of microsomal HMGR activity and microsomal SMT enzyme activity -during seedling development following seed imbibition (Figs. 3C and 3D) show: (1) that SMT activity is correlated with sterol synthesis and plant growth; (2) neither sitosterol nor 24(28)-methylene cycloartanol at 100 mM affected HMGR activity, suggesting that HMGR activity does not correlate to growth or sterol production; and (3) the rate of phytosterol turnover correlates to the activities of the first and second methylation of SMT! enzyme and not HMGR activity.
These results demonstrate that during the initial shoot development following seed imbibition sterol biosynthesis is down-regulated. Sterol that accumulates in 3-day shoots is derived from translocation of sterol originating in the seed. Subsequent com seedling development results in an up-regulation of phytosterol synthesis. Carbon flow is directed into the phytosterol pathway: Δ5-24-alkylsterols are synthesized at rates to meet the increasing demands of membrane synthesis. Cycloartenol and related C-4 methylated sterols are tumed over to Δ5-end products. The critical slow step, which is the first transformation step in phytosterol synthesis, is methylation of cycloartenol.
Fig. 4 summarizes the pathway to kinetically favored Δ5-24-alkyl sterol end products in com during development of the seedling into blades and sheaths under dark-grown conditions. Expression of SMT enzyme activities during early blade and sheath formation, and sterol specificity data, show that com synthesizes at least two different SMT enzymes: SMT! catalyzes the successive methyl transfer to produce Δ24(28)-methylene and Δ24(28)-ethylidene sterols; and SMTπ catalyzes the methyl transfer to Δ23(24)-24-methyl sterols.
Example 2. Identification of sterols required for growth of plants
The phytosterols identified in Example 1 were tested individually for their ability to support growth. In the absence of a plant sterol mutant for such studies the yeast sterol auxotroph, GL-7, was cultured in the presence of sterols identified according to Example 1, above (Li, 1996). This yeast mutant is used as a model system because it can take up sterols from the culture medium and incorporate the test sterol into the membrane lipid bilayer and proliferate. The amount of proliferation of the cells was measured in the presence and absence of hormonal levels of ergosterol, the major yeast sterol.
Sterols were classified according to their effect on growth. Those sterols sparking growth included ergosterol. Those sterols that migrated to membrane and cell structural components without affecting the rate of growth of the cells included cholesterol and sitosterol (Nes et al., 1993).
Example 3. Enzymology of sterol-converting enzymes
The sterol specificity of the microsome-bound and soluble SMT enzyme from 4-day com seedlings was determined in order to elucidate the enzymatic basis for the plant sterols identified in Example 1. Using a microsome-bound enzyme system, we observed that cycloartenol is the preferred sterol acceptor and that 24(28)-methylene lophenol was methylated to produce 24(28)-ethylidenelophenol. Table 2 summarizes the specificities to various sterol substrates using the soluble SMT enzyme from com seedlings.
Table 2
Sterol specificity of the (S)-adenosyl-L-methionine:D 24 -sterol methyl transferase
Substrate Enzyme Activity % Activity,
(dpm/min) relative to cycloartenol methylation
Cycloartenol 37,515 100 (CI)
Lanosterol 24,384 65 (CI)
Parkeol 6,002 16 (CI)
31 -Norcycloartenol 18,757 50 (CI)
24-Dehydropollinstanol 8,253 22 (CI)
Zymosterol 5,252 14 (CI)
4α-Methylzymosterol 10,504 28 (CI) 14α-Methy lzymosterol 3,376 9 (C1)
_3-Desoxyzymosterol BG 0 (C1)
Cholest-8-enol BG 0 (C1)
24(28)-Methylenelophenol 3,800 10 (C2)
4α-Methylergosta-8,24(28)-dienol 1,500 4 (C2)
Obtusifoliol BG 0 (C2)
Cycloeucalenol BG 0 (C2)
Ergosta-8,24(28)-dienol BG 0 (C2)
Ergosta-7,24(28)-dienol BG 0 (C2)
Ergosta-5 ,24(28)-dienol BG 0 (C2)
24(28)-Methylene cycloartanol BG 0 (C2)
There was little difference in the relative binding efficiencies (KOT) of sterols in the microsome-bound and soluble enzyme systems studied. There was a difference in the apparent Vmax for the substrates, but this was expected as the level of protein and total sterol endogenous sterol changes during enzyme solubilization. The properties of the soluble SMT enzyme from 4-day com was similar to that of the microsome-bound SMT enzyme from sunflowers.
The first methyl transfer was demonstrated using cycloartenol and [methyl-3H]-AdoMet incubated with a soluble enzyme preparation from 4-day shoots. In a study on methylation mechanisms operating in com, [2713C] -lanosterol was used to confirm the methylation mechanism producing a 24(28)-methylene sterol in 4-day shoots (Guo et al., 1996).
In neither incubation with cycloartenol or lanosterol was the sterol acceptor molecule methylated to the second methyl product (Nes et al., 1991; Venkatramesh et al, 1996). If the SMT is a single protein species, then there may be two binding sites on the enzyme.
The com SMT protein is a tetramer with 4 subunits of 39 kDa. A bifunctional sterol- methylating (SMT) enzyme was partially purified from 4-day etiolated Zea mays (com) shoots by the following steps:
(i) non-ionic detergent solubilization of the microsome-bound SMT enzyme; (ii) gel-filtration fractionation of the solubilized protein to produce active fractions with an apparent native molecular weight of circa 156 kd; and (iii) hydroxyapatite chromatography of active fractions.
Both methylation activities copurified approximately 200-fold.
Fig. 1 shows an HPLC-radiocount (Fig. IB) and mass spectrum (Fig. 1A) of the reaction product from 50 pooled assays from a soluble SMT enzyme (4-day seedlings) assayed with 24(28)-methylene lophenol. The second methyl transfer from 24(28)-methylene lophenol to 24(28)-ethylidene lophenol is demonstrated in this incubation. Thus the SMT enzyme from 4-day corn shoots catalyzes the successive first and second methyl transfers of an appropriate sterol acceptor molecule. Table 3 shows the effect of a series of substrate and transition state analogs on the first and second methyl transfer reactions.
Table 3
Effect of substrate and transition state analog inhibitors on
(S)-adenosyl-L-methionine: Δ24-sterol methyl transferase activity.
Inhibitor ϊntry K, relative to the K, relative to the
* no. first methyl second methyl transfer transfer
Campesterol 1 NA NA
24(28)-Methylene 2 20 μM NA cycloartanol
26 ,27-Cyclopropylidene 3 25 μM NA cycloartenol 4 55 nM 55 μM
24-(R,S)-25-Eρimino- 5 NA 75 μM lanosterol 6 NA 100 μM
Z-24(28)-Ethylidene lophenol Sitosterol
* Numbers indicate structures in Fig. 2
Various inhibitors were tested with soluble SMT enzyme from 4-day seedlings (Fig. 2). The inability of some inhibitors to affect the methylation activity of both sterol substrates suggested that the SMT enzyme has two binding sites.
SMT catalyzes two successive transmethylations from the coenzyme (S)- adenosyl-L-methionine to different substrates: cycloartenol (Δ24-4,4-dimethyl sterol) with 20 mM Km and 4 pmol/min mg protein Ymax; and 24(28)-methylene lophenol (Δ7,24(28)-4-monomethyl sterol) with 11 μM Km and 1 pmol/min/mg protein Vmax. Accordingly, cycloartenol was the preferred substrate for the first methylation reaction and 24(28)-methylene lophenol was the preferred sterol substrate for the second methylation reaction. Zymosterol (Δ8' 4-4-desmethyl sterol), a preferred sterol substrate of yeast SMT enzyme, was a poor sterol substrate of the first methylation reaction.
Substrate specificity and inhibition studies suggested two binding sites on the SMT enzyme: binding site I catalyzes a first methyl transfer to produce a 24(28)-methylene sterol; and binding site II catalyzes the second methyl transfer to produce a 24(28)-ethylidene sterol.
For Example, sitosterol (24α-ethyl cholesterol), the major end product of com sterol production in blade tissue, inhibited the second methyl transfer (100 μM K,), without affecting the first methyl transfer; campesterol (24 -methyl cholesterol) failed to inhibit either the first or second methylation reaction; 24(28)-methylenecycloartanol, a product of cycloartenol transmethylation, was not methylated; and 24(28)-methylenecycloartanol inhibited the first methyl transfer (20 μM K,) whereas it failed to inhibit the second methyl transfer. 26,27-cyclopropylidene cycloartenol, which failed to bind to the yeast SMT enzyme, was a potent competitive inhibitor of the first methylation reaction (25 μM K,), while not affecting the second methyl transfer. -The second alkylation was inhibited by product inhibition from 24(28)-ethylidene lophenol (75 mM K,), while not affecting the first methyl transfer. A transition state analog, 24-(R,S)-25-epiminolanosterol inhibited the first and second methylation reactions with a similar K, value of 55 nM and to exhibit a non-competitive type kinetic pattern. The sterol features of the substrate in the initial enzyme-substrate interaction appears to be typical of other plant SMT enzymes, i.e., a requirement for nucleophilic groups at C-3 and C-24. The 5 μM Km for the coenzyme was the same for the first and second methylation reactions.
Example 4 SMT genes from veast
The yeast SMT gene, ERG6, was derived from a yeast ERG6 genomic fragment, pRG458/erg6 (Fig. 5B; SEQ ID NO:l).
The cloned ERG6 gene was expressed in E. coli. The recombinant protein was shown to be the sterol biomethylation enzyme by enzymatic study which proved that the kinetic properties were similar to that of the native enzyme in yeast. In contrast to plant SMT which prefer cycloartenol, zymosterol, a Δ24-4-desmethyl sterol, is the preferred substrate of the yeast SMT.
The molecular weight of the yeast SMT monomer was confirmed to be 43 kD after successfully overexpressing the active protein in E. coli using a T7 promoter-based pET23a(+) vector. The overexpressed protein was visualized on SDS-PAGE gel both by Coomassie blue staining and Westem blot using a yeast SMT polyclonal antibody. The recombinant protein has also been purified from this system.
From the deduced amino acid sequence of the yeast SMT (Fig. 5A; SEQ ID NO:2) the potential AdoMet binding motif was predicted as the first conserved region identified in Fig. 5A (YEYGWGS) and based on mechanistic analysis of biomethylation described in Example 3, the amino acid tryptophan (W) was determined to be the binding site. By -site-directed mutagenesis of the ERG6 gene this amino acid was replaced with alanine. The mutated DNA was also overexpressed in E. coli by cloning into pET23a( +). This protein was not active under conditions where the wild-type protein was active.
Such a strategy provides a means to alter phytosterols by introducing inactive SMT protein into plants. The introduction of non-functional SMT monomers can result in the suppression of SMT activity, for example by affecting the ability of the cell to form a functional SMT enzyme complex, thereby leading to the formation of nonutilizable sterols. For example, suppressing the activity of the first SMTZ reaction will lead to formation of Δ23(24)-24-alkyl sterols, products of SMTπ activity. Alternatively, suppressing the activity of the second SMT: reaction will lead to the formation of Δ24 25)- 24-alkyl sterols.
Example 5 SMT genes from Arabidopsis
The SMT gene from Arabidopsis was cloned and sequenced (Fig. 6; SEQ ID NO:3). This gene was overexpressed in E. coli. Arabidopsis SMT was partially purified and characterized in stereochemical detail.
The Arabidopsis SMT gene was amplified by PCR from a cDNA library. The primers used were designed from the full-length cDNA sequence retrieved from the GeneBank (Accession number X89867). The amplified product was the full-length Arabidopsis SMT gene which was sub-cloned into a T/A cloning vector and sequenced. From the sequence data the ORF was identified. A Nde I site was created at the ATG start codon through PCR mediated site-directed mutagenesis. The full-length ORF containing a Nde 1 site at the start and a BamH I site at the stop was cloned into the pET23a(+) vector just as the ERG6 gene was in Example 4. The recombinant protein was active in transforming both cycloartenol and 24(28)-methylene lophenol to their respective alkyl products (Tong et al, 1997). In the case of cycloartenol only one product was formed, which is 24(28)-methylene cycloartanol, i.e., SMTj in Fig. 4. Since a single gene -product was able to metabolize both sterol substrates it further confirms the enzymological data in Example 3. Further, since cycloartenol metabolism by the recombinant plant SMT gave rise to only one product which also is the product of SMTT it suggests that the alternate product, cyclosadol (structure 6 in Fig. 4), is formed from an isoform (SMTπ) encoded by a different gene.
Example 6 SMT genes from com
The com sterol methyl transferase (SMT) gene was isolated from a commercial com cDNA library (Stratagene, La Jolla, CA). Five microliters of com cDNA (equivalent to 5x10 pfu) were used as template in the amplification of the SMT gene by polymerase chain reaction (PCR). Because the cDNA library was constructed in the vector Uni-Zap
XR (Stratagene), the T7 sequence in this vector was used as one of the two primers for
PCR amplification (3 'end primer). The 5' end primer (2650-1) was designed from nucleotides 2-20 of a putative SMT fragment published in Gene Bank (T23297). Thirty cycles of PCR were conducted using five units of Taq polymerase from Promega in a total volume of 100 microliters, according to the manufacturer's instructions. One microliter of PCR product from this reaction was used as the template for a second round of PCR using the T7 primer and a primer designed from nucleotides 250-268 of T23297. When the resulting reaction products were analyzed on a 1 % agarose gel, a band of 1.3 kb was seen. This PCR band was subcloned into the plasmid pGEM-T
(Promega) and was sequenced.
To obtain the 5' end of the SMT gene, a pair of primers designed from nucleotides 2-20 and 366-349 of sequence T23297, was used in the PCR amplification. A band of 366 nucleotides was obtained and sequenced. The sequence of this 366-nucleotide PCR fragment overlapped with the 1.3 kb clone for 116 nucleotides. These two fragments were joined together by PCR, using a pair of primers, 2650-1 and 3082-2. The latter primer was designed from the 1.3 kb fragment 20 nucleotides before poly A sequence. Both of the 366 bp and the 1.3 kb PCR fragments were used as the DNA templates. The -reconstructed SMT gene was ligated to the PCR cloning vector pGEM-T and was sequenced bi-directionally using the ABI Prism Automatic DNA Sequencer (Model 310).
The cloned SMT cDNA was 1497 nucleotides, with a coding region of 1032 nucleotides, which encodes 344 amino acids (Figure 10; SEQ ID NO: 6). The start codon, ATG, was located at nucleotide 66-68. There was one stop codon preceding the start codon (ATG), located at position 42-44, suggesting that the reconstructed SMT sequence contains the complete 5 'end. A poly A tail of 28 nucleotides was located 371 nucleotides downstream of the stop codon, indicating the cDNA fragment was complete at 3 'end. Therefore, this cDNA clone is a full length cDNA clone.
The deduced amino acid sequence from this cDNA clone contains 344 amino acids, encoding a polypeptide of 38.8 kiloDaltons. This deduced amino acid sequence contains all three of the proposed conservative regions for methyl transferase (Kagan and Clarke, 1994. Arch. Biochem. Biophys. 310: 417-427): LDVGCGIGGP at position 104-114 (amino acid sequence) and TLLDAVYA at position 167-174, and VLKPGQ at position 194-199. In addition, another conserved region for sterol methyl transferase, proposed by Nes (SFYEYGWGESFHFA, Guo et al.,1997. Antifungal sterol biosynthesis inhibitors. In Subcellular Biochemistry Volume 28: Cholesterol: Its function and Metabolism in Biology and Medicine, edited by Robert Bittman. Plenum Press, New York), was seen at position 60-73.
The deduced com SMT amino acids sequence was compared with amino acid sequences from other known SMT genes using GCG progams (Gap and Bestfit). The deduced corn SMT amino acid sequence shared a 93.6% similarity with an independently isolated corn SMT sequence (Genbank U79669), 88.1 % homology, 78.8% identity with soybean SMT (Genbank U43683), and a 93.9% homology, 88.3% identity with partial wheat SMT sequence (Genbank U60754 ), 58.8% homology, 39% identity with Arabidopsis thaliana (Genbank X89867), and a 66.5% homology, 50.4% identity with -yeast SMT (Genbank X74249). The high similarity between this cDNA clone and SMT genes from other plant species confirms that this cDNA clone is a full length SMT cDNA clone of Zea mays. Furthermore, since Grabenok et al. have functionally expressed their com SMT gene in a yeast expression system and found no 24-alkyl sterols other than ergosterol, this suggests that the com SMT gene isolated by my laboratory catalyzes the same stereoselective C-methylation to Δ24(28), thereby supporting the view that com synthesizes several different SMT enzymes.
A similar strategy can be used for isolating the cDNA for the SMTπ isoform. In fact, cDNA fragments isolated by the described method should be representative of both SMTj and SMTπ based on the conservation of the region from which the primers were derived.
Example 7 SMT genes from Prototheca wickerhamii
Another example of a preferred SMT gene is that from Prototheca wickerhamii. This yeast-like alga produces Δ25 27)-24-methyl sterol as the main product of transmethylation. The favored substrate is cycloartenol.
Studies from microsome preparations of P. wickerhamii have shown that the preferred substrate of the SMT is cycloartenol. However, the preferred product is not 24(28)- methylene cycloartenol but cyclolaudenol (VII) which is a Δ25(27)-24-alkyl sterol, a nonutilizable sterol.
Cloning the gene of this SMT will facilitate the introduction of this gene into plants in order to transform the plant sterol, cycloartenol, into a product, cyclolaudenol, which will lead to the accumulation of nonutilizable sterols, viz., Δ25(27)-24-alkyl sterols.
Figure imgf000040_0001
(VU)
Cloning of Prototheca SMT
Prototheca wickerhamii cells are grown to mid log phase in YPD rich medium (yeast extract - peptone - dextrose). The pelleted cells are disrupted in the presence of Tri Reagent (MRC) using 0.5 mm glass beads and a mini-Beadbeater (both from Biospec Products, Bartlesville, OK). High quality total cellular RNA is isolated according to the manufacturer's instructions.
Total cellular RNA is subjected to 3' RACE (rapid amplification of cDNA ends) and 5' RACE using reagents and protocols found in kits obtained from GibcoBRL. For 3' RACE, total cDNA is synthesized by the action of reverse transcriptase after annealing oiigo(dT)-containing primers to the poly(A)-tailed RNAs present in the unfractionated total RNA. The RNA templates are degraded and the cDNA serves as template for polymerase chain reaction (PCR) amplification. The user-supplied primer "YEYGWG" (see Rationale for primer design below) anneals to the cDNA and is extended toward the 3' end of the gene under the direction of Taq polymerase. The kit-supplied primer for extension from the 3' end to the terminus defined by the "YEYGWG" primer anneals to a sequence composed of three restriction endonuclease recognition sites that was part of the original oligo-dT containing primer. A second PCR amplification in which the primer pair is a second "nested" primer ("GCGVGG") and the kit-supplied 3' primer is performed to enrich for cDNAs representing the 3' half of SMT. Another nested primer ("ATCHAP") has been similarly used. Total cellular RNA is also subjected to 5' RACE. cDNA is synthesized by reverse transcriptase using the antisense primer "EWVMTDas". cDNA is modified at the 3' end by the addition of a polydeoxycytidine "tail" using terminal deoxynucleotidyl transferase (TdT). An initial PCR reaction is carried out using this C-tailed cDNA as template and the primers "EWVMTDas" and a kit-supplied poly-G containing primer. A second PCR reaction is carried out on this PCR product using the nested primer "ATCHAPas" and a kit-supplied primer that anneals to a part of the poly-G primer that contains restriction enzyme recognition sites. This second PCR reaction enriches for 5' SMT cDNA sequences.
The 3' RACE and 5' RACE PCR products are isolated from gels and ligated into the plasmid pPCRII (Invitrogen). Clones obtained after transformation into E. coli are characterized by sequencing. An Apa I restriction site is present in the DNA of all plants and yeast that have been sequenced in the GCGVGG motif and is present in both the 3' and 5' cDNA clones. This allows splicing of the two 3' and 5' halves of the SMT gene together, completing the entire coding region.
Rationale for primer design
The first step in designing the user-supplied primers was to examine the several very highly conserved peptide motifs in the SMTs of those plants and yeast that have been sequenced. Within these are found shorter stretches of amino acid sequences that can be encoded by a minimum number of DNA sequences, the codons of which usually only vary at the third (degenerate) base. It was also desirable that the codon preferred by 3 different yeast species according to codon usage tables found in Wada, et. al. (Nucleic Acids Res., vol 19, pi 981, 1991) be present in the mix of degenerate codons for each amino acid. Each user defined primer is thus a mixture of deoxynucleotides that defines an internal end of a PCR product. It was also reqiured that 4 or 5 of the 6 3' deoxynucleotides of each primer be perfectly matched in all species and had greater than
50% G and/or C. The first three primers described below are sense orientation primers that anneal to -antisense DNA (and the original cDNA). The fourth and fifth primers are antisense primers that anneal to the sense DNA strand of the SMT gene.
YE[Y/F/W]GWG (amino acids 81-86 of the yeast sequence; nonidentical residues at a position are in brackets) was the part of a larger conserved region of SMT that was the basis for the "YEYGWG" primer:
5' - TA[T/C]GA[A/G]T[A/G/T][T/G]GG[T/A/C]TGGGG - 3'
(Degenerate nucleotide positions are included in brackets)
The "GCGVGG" primer was suggested by the DNA sequence that encodes part of a second conserved domain (GCG[V/I]GG) at yeast amino acid residues 129-134. The sequence of primer "GCGVGG" is:
5' - GGATG[T/C]GG[T/A][G/A]T[T/C]GG[G/C]GG - 3'.
Primer "ATCHAP" is based on the DNA sequence encoding a third highly conserved domain (yeast amino acids 196-203). The primer sequence is:
5' - GCCAC[A/G/T]TG[T/C]CA[C/T]GC[T/G/A]CC - 3' .
Primer "EWVMTDas" is an antisense primer for first strand cDNA synthesis in the 5' RACE experiment. It is based on the small conserved domain at yeast amino acid residues 225-231. The sequence is:
5' - TC[A/C/G]GTC[G/A]T[T/A/G][C/A][C/A]CCA[C/T]TC - 3' .
Primer "ATCHAPas" is a nested antisense primer for the 5' RACE experiment with the sequence:
5' - GG[T/C/A]GC[A/G]TG[G/A]CA[A/C/T]GTGGC - 3' . -Example 8 SMT genes from other plants
Using the Arabidopsis cDNA or another plant derived SMT sequence as a probe, cDNA libraries from any crop of interest can be screened and corresponding clones of appropriate sizes can be isolated and sequenced. cDNA library construction and screening methodologies are well known in the art. As described in Example 6, appropriate primer combinations can be readily determined using information of the conserved regions of known sequences for various SMT genes. To confirm the identity of sequences cloned by this method, they can be compared with known plant SMT enzyme sequence and/or in vitro tranlsated and evaluated biochemically.
Example 9 Plant transformation with ERG6 DNA
To obtain transgenic plants with altered sterol profiles a DNA fragment containing the open reading frame of the SMT ERG6 gene of yeast isolated from a genomic clone was identified (Example 4). The ERG6 DNA was modified by PCR to include restriction sites for Nco I on either end of the open reading frame. This PCR procedure gave ruse to a mutaion which introduced a frameshift in the gene. This mutation made the ERG6 gene introduced into the plant untranslatable, but capable of inhibiting the endogenous tomato SMT via antisense or co-suppression mechanisms, depending upon the nature of the construct.
The modified ERG6 DNA fragment was cloned into the pUClδcpexp expression cassette vector. Clones with the ERG6 DNA in the sense as well as the antisense orientations to the 35S promoter were generated (Fig. 7).
Hind HI digestion of these clones gave rise to the ERG6 constructs that included the 35S promoter and termination sequences flanking the ERG6 open reading frame. These Hind III digested fragments were cloned to the binary vector pJTS246 that contains T-DNA border recognition sequences and the NPTII gene conferring kanamycin resistance.
The cloned binaries with either the sense or antisense ERG6 constructs were transformed into Agrobacterium tumefaciens which were cocultivated with cotyledons of tomato (Solanum lycoperiscum) to obtain transformed plant cells. From calli formed on selective medium containing kanamycin transgenic plants were produced.
The leaves from control (no inserts) and transgenic plants (with inserts) were analyzed for the transgene. DNA was extracted from leaf samples of each of the transformants and an untransformed tomato plant. The DNA extracts were quantified by A260 absorbance.
Aliquots corresponding to 200 ng DNA from each sample were used in PCR reactions for amplifying ERG6 fragments using oligonucleotide primers corresponding to the
ERG6 sequence (underlined in Fig. 8). Controls in the PCR included a sample with no template DNA and samples of the sense and antisense ERG6 containing binary plasmids.
PCR was performed under non-stringent conditions (55 °C annealing temperature for 2 min in each cycle) in 20 cycles and aliquots were electrophoresed on 0.8% agarose gels.
The primers were selected such that a 1100 bp fragment of the ERG6 DNA would be amplified (Fig. 8). All the regenerated transgemc tomato plants (Ro) carried this fragment as did the plasmid controls. There also is some non-specific amplification because of the non-stringent conditions leading to other bands appearing in the transformed plants and in the untransformed control. However, the level of these amplifications is significantly less than that of the target fragment. This confirms the presence of the ERG6 DNA in the tomato genome. Sterol analysis was performed on the nonsaponifiable lipid fraction of leaf material frqm -one regenerated plant transformed with the sense construct and one regenerated plant transformed with the antisense construct. The results are shown in Table 4.
Table 4 Sterol Composition of Tomato Plants (as % total sterol)
Sterol Control ERG6 sense ERG6 antisense insert insert
Cholesterol 29 18 20
Cholest-7-enol none 21 13
Stigmasterol 25 22 24
Sitosterol 26 27 24
Isofucosterol 20 12 19 mg sterol/g fr.wt. 16 150 380
The result confirmed that the ERG6 gene was incorporated into the transgenic plants and that the sterol compositions of the transgenic plants were changed. A novel sterol, cholest-7-enol, which is not present in control tomato plant leaves, was detected and characterized by mass spectroscopy.
A scheme for the new pathway introduced into the tomato plants due to the insertion of the yeast ERG6 gene is predicted to be as follows:
Since both the sense and antisense inserts of the ERG6 gene lead to the accumulation of the cholest-7-enol (VHI), it is likely that in both cases there is a suppression of endogenous SMT activities. This will lead to a shunt of carbon flow into an alternate minor pathway proposed for phytosterol metabolism where the first step in cycloartenol metabolism is a reduction of the C-24 double bond by a reductase enzyme. The resulting sterol, which is cycloartanol (IX), will then undergo the usual demethylation, isomerization, desaturation and reduction just as in the main pathway leading to the formation of cholest-7-enol. This is a Δ7-sterol and the double bond at C-5 is absent, -suggesting that some insects will not be able to utilize this sterol to complete their life cycles.
Figure imgf000046_0001
Figure imgf000046_0002
The regenerant (RQ) plants were allowed to flower and set fruit. Seeds were collected, and the following generation (R-T) was grown. Individual plants arising from seeds were assayed for the presence or absence of the selectable marker (NPT2) via ELISA assay for the NPT2 protein. Fifty-three plants from six Rj progeny and a nontransgenic plant were analyzed for sterol composition. The sterol profiles of these plants could be divided into four distinct groups, or phenotypes: Table 5
Means and standard deviations (Std) of sterols (as percent of total sterols) of Rj plants in the four classes of progeny identified.
Phenotype 1 2 3 4
Mean Std Mean Std Mean Std Mean Std
Sterol
Cholesterol 7.62 2.54 6.20 2.77 4.93 1.14 8.60 2.97
Campesterol 4.17 3.15 16.60 11.24 4.50 1.95 6.60 4.83
Stigmasterol 13.14 3.13 12.80 5.26 8.86 1.41 22.60 1.14
Sitosterol 11.48 2.86 11.60 2.19 9.57 1.87 16.60 3.91
Isofucosterol 13.14 2.08 7.60 3.71 9.86 2.32 14.40 4.98 b-Amyrin 12.52 3.90 9.75 5.91 10.36 3.95 8.80 1.79
Cycloartenol 31.76 5.67 31.60 4.72 49.36 4.91 28.80 6.98
24 (28) -methylene 1.14 1.46 6.80 6.61 2.17 2.12 2.00 2.00 cycloartanol
All of the Rt plants which tested negative for the NPT2 marker (and were therefore non-transgenic segregants) as well as the nontransgenic control plant displayed the normal phenotype (Phenotype 1). The R! plants which tested positive for the NPT2 marker (and were therefore transgenic) fell into all four classes. A statistical comparison was conducted for each sterol (using the arcsin transformation of the percent sterol levels; Student-Neuman-Keuls Test, 5% significance level), and a qualitative summary of the results is given below:
Table 6 Comparison of sterol phenotypes (Phenotypes 2, 3 and 4 versus normal Phenotype 1)
Sterol Phenotype 1 Phenotype 2 Phenotype 3 Phenotype 4
Cholesterol Normal Normal Low Normal
Campesterol Normal High Normal Normal
Stigmasterol Normal Normal Low High
Isofucosterol Normal Low Low Normal β-amyrin Normal Normal Normal Normal
Cycloartenol Normal Normal High Normal
24(28)- Normal Normal Normal Normal methylene cycloartanol
Sitosterol Normal Normal Normal High
The distribution of plants in the various categories (i.e. nontransgenic controls in the normal category only and the transgenics plants in all four categories) is consistent with the expectations of plants resulting from transformation with either an antisense or cosuppression constπict. Varying levels of suppression can be expected between and within progenies, thus leading to varying levels of expression of an altered sterol phenotype. Therefore, these results are consistent with the transformed ERG6 gene having a suppressive effect. More specifically, phenotypes 2 and 3 accumulate intermediates which are consistent with partial inhibition of the first or second methylation activities of sterol methyltransferase in the biosynthetic pathway. The elevated levels of sitosterol and stigmasterol (the normal endproducts) are not consistent with suppression, and cannot be explained without further study.
Independent analyses of a subset of these progeny further supports the hypothesis that suppression of the SMT gene is being observed in the transgenic lines. Table 7 below gives the sterol compositions of nontransformed and nontransgenic segregants. Table 7
-Sterol composition of control plants (nontransformed plants and nontransgenic segregants)
Plant Nontransformed G55 (nontransgenic G62 (nontransgenic Mean Std. segregant) segregant) Dev.
Sterol
Cholesterol 18 13 13 14.7 2.9
Δ°-Cholesterol - tr. 1 1.0
14-α-CH3-Δ7- - 5 5 5.0 0.0
Cholesterol
Δ7-Cholesterol - -
14-α-CH3-Δ8- 3 1 1.7 1.2 cholesterol
Zymosterol 18 - - 18.0
Δ7 ' 24-Zymosterol 5 - - 5.0
24-CH2- - 19 1 10.0 12.7
Cholesterol
Campesterol 2 8 3 4.3 3.2
Desmosterol 2 - 2.0
Δ°-Campesterol - - 1 1.0
Stigmasterol 18 20 25 21.0 3.6
Δ°-Stigmasterol - tr. 1 1.0
Sitosterol 7 13 18 12.7 5.5
Δ°-Sitosterol - - tr.
Isofucosterol 4 2 2 2.7 l._
Cycloartenol 7 19 29 18.3 11.0
24-CH2- 14 - tr. 14.0
Cycloartenol
24-CH2-Lophenol 1 - tr. 1.0
Obtusifoliol 1 - tr. 1.0 -dash lines means not detected; tr. is trace; N.D.-not determined.. NSF was chromatographed on TLC plates and bands matching 4-desmethyl-, 4-monomethyl and 4,4-dimethyl sterol standards were eluted from the plate and examined further by chromatography on 3% SE-30 columns and GC-MS. Limit of detection is 0.1 mg sterol per leaf sample. These controls can be compared with transgemc plants, the sterol composition of which are given in tables 8, 9, and 10. Table 8 Sterol composition of transgenic plants from line G3
Plant G31 G32 G34 G35 G37 G38 G39
Sterol
Cholesterol 12 10 8 10 8 11 8
Δ°-Cholesterol 1 tr. 1 1 1 tr. 1
14-α-CH3-Δ7-Cholesterol 3 - - - - - 3
Δ7-Cholesterol - 8 6 13 11 1 -
14-α-CH3-Δ8-cholesterol 1 2 2 - - - -
Zymosterol 10 5 12 - - - 8
Δ7 ' 24-Zymosterol 2 - 1 - - - 1
24-CH2-Cholesterol - - - - - - -
Campesterol 4 2 3 - - 1 1
Desmosterol - - - - - -
Δ°-Campesterol - - - - - - -
Stigmasterol 16 14 12 20 16 16 6
Δ°-Stigmasterol 1 - - tr. - - -
Sitosterol 15 9 12 10 8 16 6
Δ°-Sitosterol 1 tr. - - - - -
Isofucosterol 4 2 2 2 2 1 1
Cycloartenol 26 41 36 40 44 41 41
24-CH2-Cycloartenol 1 3 3 4 4 4 4
24-CH2-Lophenol 2 3 2 tr. 4 6 tr.
Obtusifoliol 1 1 1 tr. 2 3 tr.
-dash lines means not detected; tr. is trace; N.D.-not determined.. NSF was chromatographed on TLC plates and bands matching 4-desmethyl-, 4- monomethyl and 4,4-dimethyl sterol standards were eluted from the plate and examined further by chromatography on 3% SE-30 columns and GC- MS. Limit of detection is 0.1 mg sterol per leaf sample.
Table 9
Sterol composition of plants from line G5
Plant G51 G52 G53 G54 G56 G57 G58 G59 G510
Sterol
Cholesterol 13 5 6 11 16 11 4 15 5
Δ°-Cholesterol 1 1 1 1 1 tr. tr. 1 1
14-α-CH3-Δ7-Cholesterol 1 3 1 2 6 5 2 4 1
Δ7-Cholesterol - - - - - - - - -
14-α-CH3-Δ8-cholesterol - 1 tr. tr. 1 tr. tr. 1 1
Zymosterol - - - - - - - - -
Δ7 ' 24-Zymosterol - - - - - - - - -
24-CH2-Cholesterol - - 3 4 - 1 6 6 -
Campesterol 8 15 4 2 1 2 2 3 19
Desmosterol - - - - 2 - - - -
Δ°-Campesterol - 1 - - - - - - 1
Stigmasterol 20 6 10 13 20 17 4 11 6
Δ°-Stigmasterol - - tr. tr. - tr. - - 1
Sitosterol 21 11 7 9 9 8 3 11 1
Δ°-Sitosterol - tr. 1 tr. - tr. tr. 1 1
Isofucosterol 1 1 1 1 1 8 1 2 1
Cycloartenol 34 48 58 52 41 47 49 35 43
24-CH2-Cycloartenol 1 4 6 5 1 1 28 10 14
24-CH2-Lophenol 1 3 1 tr. - tr. 1 tr. 4
Obtusifoliol tr. 1 1 tr. - tr. tr. tr. 1
-dash lines means not detected; tr. is trace; N.D.-not determined.. NSF was chromatographed on TLC plates and bands matching 4-desmethyl-, 4-monomethyl and 4,4- dimethyl sterol standards were eluted from the plate and examined further by chromatography on 3% SE-30 columns and GC-MS. Limit of detection is 0.1 mg sterol per leaf sample.
Table 10
Sterol composition of plants from line G6
Plant G63 G65 G66 G67 G68 G69 G610
Sterol
Cholesterol 7 7 9 8 5 6 7
Δ°-Cholesterol tr. 1 1 1 tr. tr. 1
14-α-CH3-Δ7-Cholesterol 2 2 5 1 1 3 1
Δ7-Cholesterol - - - - - - -
14-α-CH3-Δ8-cholesterol 1 1 1 1 tr. 1 1
Zymosterol - - - - - - -
Δ7 ' 24-Zymosterol - - - - - - -
24-CH2-Cholesterol 2 tr. tr. - - - -
Campesterol 18 3 1 3 20 1 3
Desmosterol - - - - - - -
Δ°-Campesterol tr. - tr. tr. 1 - -
Stigmasterol 10 7 11 8 5 6 7
Δ°-Stigmasterol tr. tr. 1 tr. tr. tr. tr.
Sitosterol 13 7 7 9 8 4 7
Δ°-Sitosterol tr. 1 tr. 1 tr. Tr tr.
Isofucosterol 2 2 1 1 1 tr. 2
Cycloartenol 30 61 61 61 39 72 70
24-CH2-Cycloartenol 12 8 3 6 20 7 1
24-CH2-Lophenol 2 - - - - - -
Obtusifoliol 1 - - - - - -
-dash lines means not detected; tr. is trace; N.D.-not determined.. NSF was chromatographed on TLC plates and bands matching 4-desmethyl-, 4- monomethyl and 4,4-dimethyl sterol standards were eluted from the plate and examined further by chromatography on 3% SE-30 columns and GC-MS. Limit of detection is 0.1 mg sterol per leaf sample.
These analyses indicate that cycloartenol levels of many of the transgenic plants are significantly elevated compared to controls. The cycloartenol levels achievable by this approach are at or above the level of nonutilizable sterol necessary to have a detrimental effect on insects, as demonstrated in Example 10 below. In addition, the results are consistent with successful in vivo suppression of the first methylation catalyzed by SMT. Example 10 Sterol utilization and metabolism by Heliothis zea
•Several sterols were isolated from nature or prepared synthetically to feed to the insects.
An in vivo model was used involving Heliothis zea, cultured on a synthetic medium that was devoid of sterol, except for the test sterol added to the diet. Cycloartenol and several 24-methyl and -ethyl sterol isomers were found to inhibit insect growth in this in vivo model.
Two important sterols from com, 24-methyl cholesta-5,23-dienol and 24-methyl cholesta-5,25(27)-dienol, were found to be non-utilizable. The 9,19-cyclopropyl sterol was also non-utilizable, as were the Δ23(24)- and Δ25(27)-24-alkene sterol isomers.
Heliothis zea (com earworm) was reared on an artificial diet treated with different sterol supplements to study the relation between sterol structure and utilization in insects. H. zea eggs were used to establish a disease-free stock colony.
The stock insects were reared using sterile procedures on a pinto bean-based diet. Moths were fed 10% sucrose. Cultures were maintained at 27 + l°C, at 40 ±10% relative humidity on a 14:10 light-dark photoperiod and an artificial diet was used to rear the insects on different sterol supplements. The experimental diet contained agar, which is known to contain trace contamination of cholesterol, otherwise the experimental diet was sterol-free.
Sterols were solubilized in acetone. Aliquots of the solutions were added to the sterol- free diet in a mortar, the material mixed thoroughly with the diet, and the organic solvent allowed to evaporate. Sterols were supplied to the medium at 200 ppm (equivalent to 1 mg of sterol per experimental vessel containing one insect).
By day 20, H. zea larva are in the final stage of larval development (sixth instar), after which the insects may pupate. A single neonate larva was placed in an experimental culture vial and allowed to grow for 20 days. The fresh weight, length and instar stage of 20-day larva were recorded.
In some treatments, the larvae were allowed to grow for another 4 days to determine whether they could pupate properly and develop into moth forms. Neonate larvae of H. zea failed to molt to the second instar when sterol was absent from the diet. Some of these insects survived for more than 15 days.
Sterols isolated from the nonsaponifiable lipid fraction extracted from larvae contain long chain fatty alcohols. These fatty alcohols may comigrate with sterols during some forms of chromatography and interfere with sterol quantitation, particularly of cholesterol. Therefore, in order to confirm the identity and amount of cholesterol in the insect an aliquot of the NSF was injected into a HPLC column and the fraction corresponding to cholesterol was examined by GC-MS.
Larvae did not develop on a sterol-less medium. Δ5-sterols substituted at C-24 in the side chain with hydrogen, methylene, E- or Z-ethylidene, or a- or b-ethyl groups, cholesterol, 24(28)-methylenecholesterol, sitosterol, isofucosterol, fucosterol, clinonasterol, and stigmasterol supported larval growth to late-sixth instar. These sterols are referred to as "utilizable" sterols (Table 11 and Fig. 9). In each of the incubations, the major sterol recovered from the larvae was cholesterol, showing that H. zea operates a typical insect 24-dealkylation sterol pathway.
In contrast, the sterol requirement of H. zea could not be met satisfactorily by derivatives of 3β-cholestanol with a 9β,19-cyclopropyl group, geminal dimethyl group at C-4 (e.g., cycloartenol and lanosterol), Δ8-bond, or by side chain modified derivatives that contained the following structural features: Δ23(24)-24-methyl or 24-ethyl group, Δ24(25)-24-methyl or 24-ethyl group, or Δ25(27)-24β-ethyl group. These are referred to as "nonutilizable" sterols (Table 11 and Fig. 9). The major sterol recovered from larvae which developed on nonutilizable sterols was the -test sterol added to the medium. Competition experiments using different proportions of cholesterol and 24, 25-dihydrolanosterol (from 9/1 to 1/9 sterol mixtures) indicated that abnormal development of H. zea may be induced on < 1 to 1 sterol mixtures of utilizable and nonutilizable compounds (Table 12). Sterol absorption was related to the degree of sterol utilization and metabolism.
Table 11
Effect of sterols on growth and metabolism by Heliothis zea
Sterol Entry Growth Instar Total Sterol supplement No.1 response2 reached by sterol composition3 day 20 mg/insect (as % total sterol)
Utilizable sterols
Cholesterol 1 100 6 56 cholesterol
24(28)- 2 100 6 59 ts/cholesterol
Methylene- (16/84) cholesterol
Fucosterol 4 100 6 71 ts/cholesterol (10/90)
Isofucosterol 3 100 6 52 ts/desmosterol/ cholesterol
(8/14/78)
Sitosterol 5 100 6 66 ts/cholesterol (20/80)
Clionasterol 6 100 6 43 ts/cholesterol (50/50) (14/84) (75/25)
Stigmasterol 7 100 6 27 ts/desmosterol/ cholesterol
(15/1/84)
Nonutilizable Sterol Entry Growth Instar Total Sterol supplement No.1 response2 reached by sterol composition3 day 20 mg/insect (as % total sterol) sterols
Cholest-8-enol 13 5 3 ND ND
24-Dehydro- 14 5 3 0.6 ts/cholesterol pollinastanol (86/14)
24-Methyl- 10 50 5 6 ts/cholesterol cholesta- (80/20)
5,23-dienol
24-Ethyl 12 20 3 3 ts/cholesterol cholesta- (86/14) 5,23-dienol
24-Methyl 9 5 3 1 ts/cholesterol cholesta- (65/35)
5,24-dienol
24-Ethyl 11 10 3 ND ND cholesta- 5,24-dienol
Clereosterol 8 20 3 3 ts/cholesterol (80/20)
Ergosterol 15 30 3 5 ts/7-dehydro- cholesterol/ cholesterol
(36/41/23)
Cycloartenol 17 5 3 ND ND
Lanosterol 16 5 3 ND ND
24-Dihydro- 18 5 3 ND ND lanosterol
Structures of sterols are reported in Fig. 9.
Growth on cholesterol produced larvae that at 20 days weighed, on average, 323 mg and were 30 mm long. Generally 16 to 20 insects survived on cholesterol to pupate and develop into adult moths. The growth responses on test sterols are relative to die growth on cholesterol which is normalized to 100%. 24-methyl cholesta-5,23-dienol was found to support pupations and adult moth formation. However, these insects exhibited congenital deformities. Insects in the nonutilizable category generally weighed less than 100 mg per insect and their length ranged from
2 to 15 mm, with 6 to 12 insects alive at day 20.
Sterols isolated from insect tissues, after the gut was purged of its contents, were analyzed by RP-
HPLC and GC-MS. ND Not determined. ts Total sterol.
The most effective sterols were absorbed and incorporated into tissues from 27 to 66 mg per insect, whereas the least effective sterols were absorbed and incorporated into tissues from 0.6 to 6 mg per insect. These studies demonstrate that: (i) H. zea discriminates structural modifications in the sterol nucleus and side chain, (ii) the pathway of phytosterol dealkylation to cholesterol involves a high degree of regio- and stero-selectivity, and (iii) com produces several of the nonutilizable sterols described herein.
Table 12
Utilization of 24-dihydrolanosterol (nonutilizable) sparred with cholesterol (utilizable) by Heliothis zea
Sterol mixture Entry Growth Instar Total Sterol composition
(ratio) No. response reached sterol (As % total sterol) by day 20 mg/insect
Cholesterol 1 100 6 56 cholesterol
(100%) (100%)
Cholesterol/24, 25- 1/18 100 6 45 cholesterol/24,25- dihydrolanosterol dihydrolanosterol sterol (90:10) (93:7)
Cholesterol/24,25- 1/18 100 6 36 cholesterol/24,25- dihydrolanosterol dihydrolanosterol sterol (70:30) (88:12)
Cholesterol/24,25- 1/18 70 6 25 cholesterol/24,25- dihydrolanosterol dihydrolanosterol sterol (50:50) (75:25)
Cholesterol/24,25- 1/18 30 3 12 cholesterol/24,25- dihydrolanosterol dihydrolanosterol sterol (30:70) (50:50)
Cholesterol/24,25- 1/18 10 3 ND ND dihydrolanosterol
(10:90)
Indicates the structures in Fig. 9. The minimal dietary concentration of cholesterol necessary for larvae to grow and pupate is 0.01 % of the experimental diet. This level of cholesterol does not support a rapid rate of molting as did higher levels of cholesterol. However, diets of 0.015% cholesterol or more enhanced the rate of development of larvae. Therefore, a slightly higher amount of dietary sterol (0.02%) was used to insure that a non-limiting amount of sterol (alone or as a mixture) was available in the experimental diet, or no sterol was added to the diet to act as a control.
In all larvae treated with non-utilizable sterols, there were trace amounts of cholesterol that ranged from 80 to 350 nanograms of cholesterol per insect depending on the treatment. This source of cholesterol most likely results from carryover of cholesterol in the egg (we detected ca. 80 ng of cholesterol per egg) and from absorption of trace levels of cholesterol originally present in the agar.
As the insect increases in size, the insect may accumulate increasing amounts of cholesterol from the agar diet. Cholesterol obtained in this manner may serve as a precursor for ecdysteroid synthesis. The different effectiveness of the pair of isomers sitosterol/clionasterol and isofucosterol/fucosterol, in growth support and in their active metabolism to cholesterol indicates that the 24-dealkylation pathway may operate stereoselectively.
Developmental outcomes of H. zea larva that proceeded into moths were compared. One insect was reared on a utilizable (cholesterol treatment) sterol and the other insect(s) was reared on a non-utilizable (24-methyl cholesta-5,23-dienol treatment) sterol.
Most of the insects reared on non-utilizable sterols failed to develop beyond the third instar (Table 11), indicating they were ineffective cholesterol surrogates and harmful to growth and development. Some of the non-utilizable sterol treatments were found to pupate and develop into moths. However, these moths possessed incompletely developed wings and legs.
Table 11 and Fig. 9 show that the position of the double bond in the sterol side chain and nucleus is critical to sterol-controlled growth. The inability of cholest-8-enol to support growth suggests that H. zea cannot transform 9β,19-cyclopropyl sterols to c o
Δ -sterols. Cyclopropyl sterols must pass through an Δ -sterol intermediate to give rise to a Δ5-sterol. Blocking this process will lead to the formation of non-utilizable sterols. These results indicate for the first time that several sterols synthesized by com should be unsuitable as sterol replacements of cholesterol.
All of the compositions and methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. While the compositions and methods of this invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations may be applied without departing from the concept, spirit and scope of the invention. More specifically, it will be apparent that certain agents which are both chemically and physiologically related may be substituted for the agents described herein while the same or similar results would be achieved. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims.
BIBLIOGRAPHY
Akisha et al. in: "Physiology and Biochemistry of Sterols" (G.W. Patterson and W. David Nes, Eds.) (1992) American Oil Chemists' Society Press, pp. 172-228.
Armstrong et al. Field evaluation of European com borer control in progeny of 173 transgenic corn events expressing the insecticidal protein from Bacillus thuringinesis. Crop Science (1995) vol. 35 pp. 550-557
Battraw and Hall. Histochemical analysis of CaMV 35S promoter-beta-glucuronidase gene expression in transgenic rice plants. Plant Mol. Biol. (1990) vol. 15 pp. 527-538
Bird and Ray. Manipulation of plant gene expression by antisense RNA. Biotechnology & Genetic Engineering Reviews 9:207-27, 1991
Bouhida et al.. An analysis of the complete sequence of a sugarcane baciUiform virus genome infectious to banana and rice. Journal General Virology (1993) vol. 74 pp. 15-
22
Bouvier-Nave et al. Eur. J. Biochem 246: 518-529 ( 1997)
Bower and Birch. Transgenic sugarcane plants via microprojectile bombardment. Plant J. (1992) vol. 2 pp. 409-416
Bryant. Successful genetic engineering of a cereal crop species transgenic rye obtained by plasmid injection into floral tiller. Trends Biotechnol. vol. 5 pp. 60-61
Bytebier et al. T-DNA organization in tumor cultures and transgenic plants of the monocotyledon Asparagus officinalis. Proc. Natl. Acad. Sci. (1987) vol. 84 pp. 5345- 5349
Christou et al. Stable transformation of soybean callus by DNA-coated gold particles. Plant Physiol. (1988) vol. 87 pp. 671-674 Christou et al. Production of transgenic rice (Oryza staiva L.) plants from agronomically important indica and japonica varieties via electric discharge particle acceleration of exogenous DNA into immature zygotic embryos. (1991) vol. 9 pp. 957-962
Cheng et al. Efficient transformation of papaya by coat protein gene of papaya ringspot virus mediated by Agrobacterium following liquid-phase wounding of embryogenic tissues with carborundum. Plant Cell Reports (1996) vol. 16 pp. 127-132
Corey et al. Proc. Nat. Acad. Sci. 90: 11628-11632 (1993)
Coruzzi et al. Tissue-specific and light-regulated expression of a pea nuclear gene encoding the small subunit of ribulose-l,5-bisphosphate. EMBO J. (1984) vol. 3 pp. 1671-1679
Coste et al. Proc. Nat. Acad. Sci 84, pp. 643-647 (1987)
De Kathen and Jacobsen. Agrobacterium tumefaciens mediated transformation of pisum sativum L. using binary and cointegrate vectors. Plant Cell Reports (1990) vol. 9 pp. 276-279
Fletcher, R.A. et al., 1988, in: D. Berg et al. (Eds.) STEROL BIOSYNTHESIS INHIBITORS-PHARMACEUTICAL AND AGROCHEMICAL ASPECTS, Ellis Horwood, pp 321-331
Fraley et al. Expression of bacterial genes in plant cells. Proc. Natl. Acad. Sci. (1983) vol. 80 pp. 4803-4807.
Fromm et al. UCLA Symposium on Molecular Strategies for Crop Improvement, Apr. 16- 22. Keystone, CO. (1990)
Gachotte et al. The Plant Journal 9: 391-398 (1996)
Gibson and Shillitoe. Ribozymes. Their fucntions and strategies for their use. Molecular Biotechnology 7(2): 125-37 (1997) Gordon-Kamm et al. Transformation of maize cells and regeneration of fertile transgenic - plants. Plant Cell, Vol. 2, pp. 603-618 (1990)
Guo et al. Developmental Regulation of Sterol Biosynthesis in Zea mays. Lipids 30: 3, p. 203-219 (1995)
Guo et al. Stereochemistry of Hydrogen Migration from C-24 to C-25 during Phytosterol Biomethylation. J. Am. Chem. Soc. 118, pp. 8507-8508 (1996)
Guo et al. Phytosterol Biosynthesis: Isotope Effects Associated with Biomethylation Formation to 24-Alkene Sterol Isomers. Tetrahedron Letters 37: 38, pp. 6823-6826 (1996)
Grabenok et al. Plant Mol. Biol. 34: 891-896 (1997)
Haeuser, C. et al 1990 J. Plant Physiol. 137: 201-207
Hinchee et al. in PLANT CELL AND TISSUE CULTURE (1994), pp.231-271, Vasil and Thorpe (eds.), Kluwer Academic Publishers
Horn et al. Transgenic plants of orchardgrass Dactylis glomerata L. from protoplasts. Plant Cell Reports (1988) vol. 7 pp. 469-472
Husselstein et al. FEBS Letters 381 : 87-92 (1996)
Koziel et al. Transgenic maize plants for the control of European com borer. Abstract, ACS annual meeting, Chicago, II, Aug 22-27, 1993. (1993)
Li, S. Stereochemical Studies on the Metabolism of Sterols by S. Cervesiae. M.S. Thesis, Texas Tech University (1996) pp. 1-123.
Medberry and Olszewski. Identification of cis elements involved in commelina yellow mottle virus promoter activity. Plant Journal (1993) vol. 3 pp. 619-626 Moffatt et al. The adenine phosphoribosyltransferase-encoding gene of Arabidopsis - thaliana. Gene (1994) vol 143 pp. 211-216
Nes et al. Structural Requirements for Transformation of Substrates by the (S)-Adenosyl- L-methionine: Δ24(25)-Sterol Methyl Transferase. J. Bio. Chem. 266: 23, pp. 15202- 15212 (1991)
Nes et al. Arch. Biochem Biophys. 300, pp. 724-733 (1993)
Nes et al. Sterol Utilization and Metabolism by Heliothis zea. Lipids (1997) vol 32, no 11
Ni et al. Strength and tissue specificity of chimeric promoters derived from the octopine and mannopine synthase genes. Plant J. (1995) vol. 7 pp. 661-676
Odell et al. Identification of DNA sequences required for activity of the cauliflower mosaic virus 35S promoter. Nature (1985) vol. 313 pp. 810-812
Ritchie and Hodges, in: TRANSGENIC PLANTS (1993), Vol.l, pp.147-178, Shain-dow Kung (Ed.), Academic Press Inc.
Rhodes et al. Science (1988) vol. 240 p. 204
Sanger et al. Characteristics of a strong promoter from figwort mosaic virus: comparison with the analogous 35 S promoter from cauliflower mosaic virus and the regulated mannopine synthase promoter. Plant Mol. Biol. (1990) vol. 14 pp. 433-443
Sambrook, J., E. F. Fritsch, and T. Maniatis (1989) Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
Schroeder et al. Transformation and regeneration of two cultivars of pea Pisum sativum L. Plant Physiol. (1993) vol. 101 pp. 751-757
Schuch, W. Using antisense RNA to study gene function. Symposia of the Society for Experimental Biology 45:117-27, 1991 Schuler et al. Nucleic Acids Res. (1982) vol. 10 pp. 8225-8244
Shi et al. J.Bio.Chem. (1996) 271 : 9384-9389
Somers et al. Bio/Technology (1992) vol. 10 pp. 1589-1594
Steponkus, P.L. 1984, Annu. Rev. Plant Physiol. 35: 543-584
Tong et al. Tetrahedron Letters 38: 35, pp. 6115-6118 (1997)
Toriyama et al. Bio/Technology (1988) vol. 6 p. 10
Vasil et al. Bio/Technology (1992) vol. 10 pp. 667-674
Venkatramesh et al. Biochimica Biophysica Acta 1299 (1996) 313-324
Wan and Lemaux Plant Physiol. (1994) vol. 104 pp. 37-48
Wang et al. Bio/Technology (1992) vol. 10 p. 691
Weeks et al. Plant Physiol (1993) vol. 102 pp. 1077-1084
Xu et al. Rice triosephosphate isomerase gene 5' sequence directs beta-glucuronidase activity in transgenic tobacco but requires an intron for expression in rice. Plant Physiology (1994) vol. 106 pp. 459-467
Yang et al., Plant Cell Reports 15:459-464 (1996)
Zhong et al. Analysis of the functional activity of the 1.4 kb 5' region of the rice actin 1 gene in stable transgenic plants of maize (Zea mays L.). Plant Science (1996) vol. 116 pp. 73-84. SEQUENCE LISTING
(1) GENERAL INFORMATION:
(i) APPLICANT: NES, DAVID W.
(ii) TITLE OF INVENTION: TRANSGENIC PLANTS WITH MODIFIED STEROL COMPOSITIONS
(iii) NUMBER OF SEQUENCES: 6
(iv) CORRESPONDENCE ADDRESS:
(A) ADDRESSEE: ARNOLD, WHITE & DURKEE (B) STREET: P.O. BOX 4433
(C) CITY: HOUSTON
(D) STATE: TX
(E) COUNTRY: USA
(F) ZIP: 77210-4433
(v) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Floppy disk
(B) COMPUTER: IBM PC compatible
(C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentin Release #1.0, Version #1.30
(vi) CURRENT APPLICATION DATA:
(A) APPLICATION NUMBER: US 60/033,923
(B) FILING DATE: 26 -DEC- 1996 (C) CLASSIFICATION:
(viii) ATTORNEY/AGENT INFORMATION:
(A) NAME: KAMMERER, PATRICIA A.
(B) REGISTRATION NUMBER: 29,775 (C) REFERENCE/DOCKET NUMBER: MOBT148
(ix) TELECOMMUNICATION INFORMATION:
(A) TELEPHONE: 713/787-1400
(B) TELEFAX: 713/787-1440
(2) INFORMATION FOR SEQ ID NO : 1 :
(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1320 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: double
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: TTACTTTCGA TTTAAGTTTT ACATAATTTA AAAAAACAAG AATAAAATAA TAATATAGTA 60
GGCAGCATAA GATGAGTGAA ACAGAATTGA GAAAAAGACA GGCCCAATTC ACTAGGGAGT 120
TACATGGTGA TGATATTGGT AAAAAGACAG GTTTGAGTGC ATTGATGTCG AAGAACAACT 180 CTGCCCAAAA GGAAGCCGTT CAGAAGTACT TGAGAAATTG GGATGGTAGA ACCGATAAAG 240
ATGCCGAAGA ACGTCGTCTT GAGGATTATA ATGAAGCCAC ACATTCCTAC TATAACGTCG 300
TTACAGATTT CTATGAATAT GGTTGGGGTT CCTCTTTCCA TTTCAGCAGA TTTTATAAAG 360
GTGAGAGTTT CGCTGCCTCG ATAGCAAGAC ATGAACATTA TTTAGCTTAC AAGGCTGGTA 420
TTCAAAGAGG CGATTTAGTT CTCGACGTTG GTTGTGGTGT TGGGGGCCCA GCAAGAGAGA 480 TTGCAAGATT TACCGGTTGT AACGTCATCG GTCTAAACAA TAACGATTAC CAAATTGCCA 540
AGGCAAAATA TTACGCTAAA AAATACAATT TGAGTGACCA AATGGACTTT GTAAAGGGTG 600
ATTTCATGAA AATGGATTTC GAAGAAAACA CTTTCGACAA AGTTTATGCA ATTGAGGCCA 660
CATGTCACGC TCCAAAATTA GAAGGTGTAT ACAGCGAAAT CTACAAGGTT TTGAAACCGG 720
GTGGTACCTT TGCTGTTTAC GAATGGGTAA TGACTGATAA ATATGACGAA AACAATCCTG 780 AACATAGAAA GATCGCTTAT GAAATTGAAC TAGGTGATGG TATCCCAAAG ATGTTCCATG 840
TCGACGTGGC TAGGAAAGCA TTGAAGAACT GTGGTTTCGA AGTCCTCGTT AGCGAAGACC 900
TGGCGGACAA TGATGATGAA ATCCCTTGGT ATTACCCATT AACTGGTGAG TGGAAGTACG 960
TTCAAAACTT AGCTAATTTG GCCACATTTT TCAGAACTTC TTACTTGGGT AGACAATTTA 1020
CTACAGCAAT GGTTACTGTA ATGGAAAAAT TAGGTCTAGC CCCAGAAGGT TCCAAGGAAG 1080 TTACTGCTGC TCTAGAAAAT GCTGCGGTTG GTTTAGTTGC CGGTGGTAAG TCCAAGTTAT 1140
TCACTCCAAT GATGCTTTTC GTCGCTAGGA AGCCAGAAAA CGCCGAAACC CCCTCCCAAA 1200
CTTCCCAAGA AGCAACTCAA TAAATTCACT AGATCAATAA GATTCAAATA AAGCGCACGA 1260 TATATACCTA TTTTCCTATA TATGCAGATA AAAAGATAGC ACGTTCATTG CTAGCAGGCC 1320
(2) INFORMATION FOR SEQ ID NO : 2 :
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 383 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: (D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:
Met Ser Glu Thr Glu Leu Arg Lys Arg Gin Ala Gin P e Thr Arg Glu 1 5 10 15
Leu His Gly Asp Asp lie Gly Lys Lys Thr Gly Leu Ser Ala Leu Met 20 25 30
Ser Lys Asn Asn Ser Ala Gin Lys Glu Ala Val Gin Lys Tyr Leu Arg 35 40 45
Asn Trp Asp Gly Arg Thr Asp Lys Asp Ala Glu Glu Arg Arg Leu Glu 50 55 60 Asp Tyr Asn Glu Ala Thr His Ser Tyr Tyr Asn Val Val Thr Asp Phe 65 70 75 80
Tyr Glu Tyr Gly Trp Gly Ser Ser Phe His Phe Ser Arg Phe Tyr Lys 85 90 95
Gly Glu Ser Phe Ala Ala Ser lie Ala Arg His Glu His Tyr Leu Ala 100 105 110
Tyr Lys Ala Gly lie Gin Arg Gly Asp Leu Val Leu Asp Val Gly Cys 115 120 125
Gly Val Gly Gly Pro Ala Arg Glu lie Ala Arg Phe Thr Gly Cys Asn 130 135 140 Val lie Gly Leu Asn Asn Asn Asp Tyr Gin lie Ala Lys Ala Lys Tyr 145 150 155 160
Tyr Ala Lys Lys Tyr Asn Leu Ser Asp Gin Met Asp Phe Val Lys Gly 165 170 175
Asp Phe Met Lys Met Asp Phe Glu Glu Asn Thr Phe Asp Lys Val Tyr 180 185 190
Ala lie Glu Ala Thr Cys His Ala Pro Lys Leu Glu Gly Val Tyr Ser 195 200 205
Glu lie Tyr Lys Val Leu Lys Pro Gly Gly Thr Phe Ala Val Tyr Glu 210 215 220 Trp Val Met Thr Asp Lys Tyr Asp Glu Asn Asn Pro Glu His Arg Lys 225 230 235 240 lie Ala Tyr Glu lie Glu Leu Gly Asp Gly lie Pro Lys Met Phe His 245 250 255
Val Asp Val Ala Arg Lys Ala Leu Lys Asn Cys Gly Phe Glu Val Leu 260 265 270
Val Ser Glu Asp Leu Ala Asp Asn Asp Asp Glu lie Pro Trp Tyr Tyr 275 280 285
Pro Leu Thr Gly Glu Trp Lys Tyr Val Gin Asn Leu Ala Asn Leu Ala 290 295 300 Thr Phe Phe Arg Thr Ser Tyr Leu Gly Arg Gin Phe Thr Thr Ala Met 305 310 315 320
Val Thr Val Met Glu Lys Leu Gly Leu Ala Pro Glu Gly Ser Lys Glu 325 330 335
Val Thr Ala Ala Leu Glu Asn Ala Ala Val Gly Leu Val Ala Gly Gly 340 345 350
Lys Ser Lys Leu Phe Thr Pro Met Met Leu Phe Val Ala Arg Lys Pro 355 360 365
Glu Asn Ala Glu Thr Pro Ser Gin Thr Ser Gin Glu Ala Thr Gin 370 375 380 (2) INFORMATION FOR SEQ ID NO: 3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1420 base pairs
(B) TYPE: nucleic acid (C) STRANDEDNESS: double
(D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3:
CTCTCTCTCT CTCTCTCTTG GTCTTCCTCA CTCTTAACGA AAATGGACTC TTTAACACTC 60
TTCTTCACCG GTGCACTCGT CGCCGTCGGT ATCTACTGGT TCCTCTGCGT TCTCGGTCCA 120 GCAGAGCGTA AAGGCAAACG AGCCGTAGAT CTCTCTGGTG GCTCAATCTC CGCCGAGAAA 180
GTCCAAGACA ACTACAAACA GTACTGGTCT TTCTTCCGCC GTCCAAAAGA AATCGAAACC 240
GCCGAGAAAG TTCCAGACTT CGTCGACACA TTCTACAATC TCGTCACCGA CATATACGAG 300
TGGGGATGGG GACAATCCTT CCACTTCTCA CCATCAATCC CCGGAAAATC TCACAAAGAC 360
GCCACGCGCC TCCACGAAGA GATGGCGGTA' GATCTGATCC AAGTCAAACC TGGTCAAAAG 420 ATCCTAGACG TCGGATGCGG TGTCGGCGGT CCGATGCGAG CGATTGCATC TCACTCGCGA 480
GCAACGTAGT CGGGATTACA ATAAACGAGT ATCAGGTGAA CAGAGCTCGT CTCCACAATA 540
AGAAAGCTGG TCTCGACGCG CTTTGCGAGG TCGTGTGTGG TAACTTCCTC CAGATGCCGT 600
TCGATGACAA CAGTTTCGAC GGAGCTTATT CCATCGAAGC CACGTGTCAC GCGCCGAAGC 660
TGGAAGAAGT GTACGCAGAG ATCTACAGGG TGTTGAAACC CGGATCTATG TATGTGTCGT 720 ACGAGTGGGT TACGACGGAG AAATTTAAGG CGGAGGATGA CGAACACGTG GAGGTAATCC 780
AAGGGATTGA GAGAGGCGAT GCGTTACCAG GGCTTAGGGC TTACGTGGAT ATAGCTGAGA 840
CGGCTAAAAA GGTTGGGTTT GAGATAGTGA AGGAGAAGGA TCTGGCGAGT CCACCGGCTG 900
AGCCGTGGTG GACTAGGCTT AAGATGGGTA GGCTTGCTTA TTGGAGGAAT CACATTGTGG 960
TTCAGATTTT GTCAGCGGTT GGAGTTGCTC CTAAAGGAAC TGTTGATGTT CATGAGATGT 1020 TGTTTAAGAC TGCTGATTGT TTGACCAGAG GAGGTGAAAC CGGAATATTC TCTCCGATGC 1080
ATATGATTCT CTGCAGAAAA CCGGAGTCAC CGGAGGAGAG TTCTTGAGAA AGGTAGAAAG 1140
GAAACATCAC CGGAAAAAGT ATGGAGAATT TTCTCAATTT GTTTTTATTT TTAAGTTAAA 1200 TCAACTTGGT TATTGTACTA TTTTTGTGTT TTAATTTGGT TTGTGTTTCA AGAATTATTA 1260
GTTTTTTTTT GTTTTGTTGC ATATGAGAAT CTTACTCTTG ATTTCTCCGC CGTAGAGCCG 1320
GCGAGACATA GGGGATTATT AGTATTTTTA AGTGTGTTTA AGATTGATTA ACAAGTTAGT 1380
AAAATAAAAT GTACTTAGGT GTCGAAAAAA AAAGGAATTC 1420
(2) INFORMATION FOR SEQ ID NO:4:
(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 361 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:
Met Asp Ser Leu Thr Leu Phe Phe Thr Gly Ala Leu Val Ala Val Gly 1 5 10 15 lie Tyr Trp Phe Leu Cys Val Leu Gly Pro Ala Glu Arg Lys Gly Lys 20 25 30
Arg Ala Val Asp Leu Ser Gly Gly Ser lie Ser Ala Glu Lys Val Gin 35 40 45 Asp Asn Tyr Lys Gin Tyr Trp Ser Phe Phe Arg Arg Pro Lys Glu lie 50 55 60
Glu Thr Ala Glu Lys Val Pro Asp Phe Val Asp Thr Phe Tyr Asn Leu 65 70 75 80
Val Thr Asp lie Tyr Glu Trp Gly Trp Gly Gin Ser Phe His Phe Ser 85 90 95
Pro Ser He Pro Gly Lys Ser His Lys Asp Ala Thr Arg Leu His Glu 100 105 110 Glu Met Ala Val Asp Leu He Gin Val Lys Pro Gly Gin Lys He Leu 115 120 125
Asp Val Gly Cys Gly Val Gly Gly Pro Met Arg Ala He Ala Ser His 130 135 140
Ser Arg Ala Asn Val Val Gly He Thr He Asn Glu Tyr Gin Val Asn 145 150 155 160
Arg Ala Arg Leu His Asn Lys Lys Ala Gly Leu Asp Ala Leu Cys Glu 165 170 175
Val Val Cys Gly Asn Phe Leu Gin Met Pro Phe Asp Asp Asn Ser Phe 180 185 190
Asp Gly Ala Tyr Ser He Glu Ala Thr Cys His Ala Pro Lys Leu Glu 195 200 205 Glu Val Tyr Ala Glu He Tyr Arg Val Leu Lys Pro Gly Ser Met Tyr 210 215 220
Val Ser Tyr Glu Trp Val Thr Thr Glu Lys Phe Lys Ala Glu Asp Asp 225 230 235 240
Glu His Val Glu Val He Gin Gly He Glu Arg Gly Asp Ala Leu Pro 245 250 255
Gly Leu Arg Ala Tyr Val Asp He Ala Glu Thr Ala Lys Lys Val Gly 260 265 270
Phe Glu He Val Lys Glu Lys Asp Leu Ala Ser Pro Pro Ala Glu Pro 275 280 285 Trp Trp Thr Arg Leu Lys Met Gly Arg Leu Ala Tyr Trp Arg Asn His 290 295 300
He Val Val Gin He Leu Ser Ala Val Gly Val Ala Pro Lys Gly Thr 305 310 315 320
Val Asp Val His Glu Met Leu Phe Lys Thr Ala Asp Cys Leu Thr Arg 325 330 335
Gly Gly Glu Thr Gly He Phe Ser Pro Met His Met He Leu Cys Arg 340 345 350
Lys Pro Glu Ser Pro Glu Glu Ser Ser 355 360 (2) INFORMATION FOR SEQ ID NO: 5:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1320 base pairs
(B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID NO : 5 :
TTACTTTCGA TTTAAGTTTT ACATAATTTA AAAAAACAAG AATAAAATAA TAATATAGTA 60
GGCAGCATAA GATGAGTGAA ACAGAATTGA GAAAAAGACA GGCCCAATTC ACTAGGGAGT 120 TACATGGTGA TGATATTGGT AAAAAGACAG GTTTGAGTGC ATTGATGTCG AAGAACAACT 180
CTGCCCAAAA GGAAGCCGTT CAGAAGTACT TGAGAAATTG GGATGGTAGA ACCGATAAAG 240
ATGCCGAAGA ACGTCGTCTT GAGGATTATA ATGAAGCCAC ACATTCCTAC TATAACGTCG 300
TTACAGATTT CTATGAATAT GGTTGGGGTT CCTCTTTCCA TTTCAGCAGA TTTTATAAAG 360
GTGAGAGTTT CGCTGCCTCG ATAGCAAGAC ATGAACATTA TTTAGCTTAC AAGGCTGGTA 420 TTCAAAGAGG CGATTTAGTT CTCGACGTTG GTTGTGGTGT TGGGGGCCCA GCAAGAGAGA 480
TTGCAAGATT TACCGGTTGT AACGTCATCG GTCTAAACAA TAACGATTAC CAAATTGCCA 540
AGGCAAAATA TTACGCTAAA AAATACAATT TGAGTGACCA AATGGACTTT GTAAAGGGTG 600
ATTTCATGAA AATGGATTTC GAAGAAAACA CTTTCGACAA AGTTTATGCA ATTGAGGCCA 660
CATGTCACGC TCCAAAATTA GAAGGTGTAT ACAGCGAAAT CTACAAGGTT TTGAAACCGG 720 GTGGTACCTT TGCTGTTTAC GAATGGGTAA TGACTGATAA ATATGACGAA AACAATCCTG 780
AACATAGAAA GATCGCTTAT GAAATTGAAC TAGGTGATGG TATCCCAAAG ATGTTCCATG 840
TCGACGTGGC TAGGAAAGCA TTGAAGAACT GTGGTTTCGA AGTCCTCGTT AGCGAAGACC 900
TGGCGGACAA TGATGATGAA ATCCCTTGGT ATTACCCATT AACTGGTGAG TGGAAGTACG 960 TTCAAAACTT AGCTAATTTG GCCACATTTT TCAGAACTTC TTACTTGGGT AGACAATTTA 1020 CTACAGCAAT GGTTACTGTA ATGGAAAAAT TAGGTCTAGC CCCAGAAGGT TCCAAGGAAG 1080
TTACTGCTGC TCTAGAAAAT GCTGCGGTTG GTTTAGTTGC CGGTGGTAAG TCCAAGTTAT 1140
TCACTCCAAT GATGCTTTTC GTCGCTAGGA AGCCAGAAAA CGCCGAAACC CCCTCCCAAA 1200
CTTCCCAAGA AGCAACTCAA TAAATTCACT AGATCAATAA GATTCAAATA AAGCGCACGA 1260
TATATACCTA TTTTCCTATA TATGCAGATA AAAAGATAGC ACGTTCATTG CTAGCAGGCC 1320
(2) INFORMATION FOR SEQ ID NO: 6:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1497 base pairs (B) TYPE: nucleic acid
(C) STRANDEDNESS: double
(D) TOPOLOGY: linear
( ix) FEATURE :
(A) NAME/KEY : modif iedjoase
(B) LOCATION: 1419
(D) OTHER INFORMATION: /mod_base= OTHER /note= "A or C or G or T"
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: AGACTCTGGT TCTGACATGC AGCAATTATT GCAGGTGCAT TTGATCCGTC CCGGCCGCCT 60
ACACGATGTC CAAGTCGGGA GCGCTGGATC TTGCTTCTGG CCTCGGAGGG AAGATCAACA 120
AGGTGGAAGT CAAGTCGGCC GTCGATGAGT ATGAGAAATA TCATGGATAC TATGGAGGGA 180
AGGAGGAAGC AAGGAAGTCC AACTATACTG ATATGGTTAA TAAATACTAT GATCTTGCCA 240
CTAGCTTCTA TGAGTATGGT TGGGGTGAAT CCTTCCACTT TGCTCACAGA TGGAATGGAG 300 AATCCTTACG TGAAAGCATC AAGCGACATG AGCATTTTCT TGCCCTGCAA CTTGGTTTGA 360
AACCAGGAAT GAAGGTTTTA GATGTGGGCT GTGGAATAGG TGGACCACTG AGAGAAATTG 420
CAAGATTTAG CTCAACTTCA GTTACCGGAT TGAATAACCA CGAATACCAG ATAACCAGGG 480 GAAAGGAGCT CAACCGTTTA GCAGGAATTA GTGGAACATG TGATTTTGTC AAGGCGGACT 540
TCATGAAGAT GCCGTTCGAT GACACACTTT TGGATGCTGT TTACGCCATT GAGGCAACAT 600
GTCATGCACC TGATCCAGTT GGTTGCTACA AGGAGATATA TCGTGTGTTG AAGCCTGGCC 660
AGTGCTTTGC CGTGTACGAG TGGTGCGTTA CGGATCACTA TGATCCTAAC AATGCAACCC 720
ACAAAAGGAT CAAGGATGAA ATTGAGCTTG GCAATGGCCT GCCAGATATC AGAAGCACTC 780 CGCAATGTCT CCGGGCTCTA AAAGACGCCG GGTTTGACGT TGTTTGGGAT AAGGATCTTG 840
CTGAAGATTC TCCCTTGCCT TGGTACTTGC CCTTGGACTC CAGCCGATGC TCACTGAGTA 900
GCTTCCGTCG ACCTCCTGTC GGGACGCATG ATACCCGCAC AATGGTCAAG GCCCTGGAGT 960
ACGTTGGTCT TGCTCCGCAG GGCAGTGAGA GGTCTCTAGT TTTCCTGGAG AAGGCTGCAG 1020
AAGGGCTGGT AGAGGGCGGA AAGAAGGAGA TCTTCACGCC AATGTACTTC TTTTTTGTTC 1080 GGAAGCCTCT TCTGGAATGA GCTCTTGGAT CACCTTTTCA GAGAGAGAAG GCAAGTGGTC 1140
ATTTCGAAGA AGCCGAGGAG AGGGAACCTG GAATCAAGAA AACCTTCAGC TCTCCTGTGT 1200
AGGAGGAAAG TTAACGAACA GTGTAGTAAC TGTTCAGCTC TGTGTTTATT CAGTTGTTTT 1260
GCTGCTTGAG GTTATTCGTT TCTAGGTGGG GGTTGGAATC CTTTTCGCCA TAAACCTCTC 1320
AGTGGCATAA ATAAGATGGT TTGCATAAGA GTACTTCATG GATACCGTAA GGGCTACTAC 1380 TGAAAGAGAA ATGTTTAAGC AGCATGGTAT GTGAGCAANT AGTGATAATT ATTCCATCCT 1440
TTTTTTTAAT ATAAAGCAGG AGTTTTGTCA AAAAAAAAAA AAAAAAAAAA AAAAAAA 1497

Claims

WHAT IS CLAIMED IS:
1. A double stranded DNA molecule comprising: a promoter which functions in plants to cause the production of an RNA sequence, operably linked to a DNA coding sequence which encodes an enzyme which binds a first sterol and produces a second sterol, operably linked to a 3' non-translated region which causes the polyadenylation of the 3' end of the RNA sequence; wherein the promoter is heterologous with respect to the DNA sequence.
2. The DNA molecule of claim 1, wherein the DNA coding sequence is in the sense orientation.
3. The DNA molecule of claim 1, wherein the DNA coding sequence is in the antisense orientation.
4. The DNA molecule of claim 1, wherein the first sterol is selected from the group consisting of 4-methyl sterol, 9β,19-cyclopropyl sterol, Δ8-sterol, 14α-methyl sterol, Δ23,24-alkyl sterol, Δ24,24-alkyl sterol and Δ25(27), 24-alkyl sterol.
5. The DNA molecule of claim 1, wherein the first or second sterol lacks a Δ5 group.
6. The DNA molecule of claim 1, wherein the DNA coding sequence encodes an enzyme selected from the group consisting of a S-adenosyl-L-methionine-Δ24(25)-sterol methyl transferase, a C-4 demethylase, a cycloeucalenol to obtusifoliol-isomerase, a 14α-methyl demethylase, a Δ8 to Δ7-isomerase, a Δ7-C-5-desaturase and a 24,25- reductase.
7. The DNA molecule of claim 1, wherein the DNA coding sequence encodes an S- adenosyl-L-metbionine-Δ24(25)-sterol methyl transferase (SMT).
8. The DNA according to claim 7, wherein the SMT is from plants or yeast.
9. The DNA according to claim 7, wherein the SMT is derived from Zea mays, Arabidopsis thaliana or Prototheca wickerhamii.
10. The DNA according to claim 7, wherein the SMT is yeast ERG6.
11. A transgenic plant comprising a double stranded DNA molecule comprising: a promoter which functions in plants to cause the production of an RNA sequence, operably linked to a DNA coding sequence which encodes an enzyme which binds a first sterol and produces a second sterol, operably linked to a 3' non-translated region which causes the polyadenylation of the 3' end of the
RNA sequence; wherein the promoter is heterologous with respect to the
DNA sequence.
12. The plant of claim 11, wherein the DNA coding sequence is in the sense orientation.
13. The plant of claim 11, wherein the DNA coding sequence is in the antisense orientation.
14. The plant of claim 11, wherein the first sterol is selected from the group consisting of 4-methyl sterol, 9β,19-cyclopropyl sterol, Δ8-sterol, 14α-methyl sterol, Δ23,24-alkyl sterol, Δ24,24-alkyl sterol and Δ25(27), 24-alkyl sterol.
15. The plant of claim 11, wherein the first or second sterol lacks a Δ5 group.
16. The plant of claim 11, wherein the DNA coding sequence encodes an enzyme selected from the group consisting of a S-adenosyl-L-methionine-Δ24(25)-sterol methyl transferase, a C-4 demethylase, a cycloeucalenol to obtusifoliol-isomerase, a 14α-methyl demethylase, a Δ8 to Δ7-isomerase, a Δ7-C-5-desaturase and a 24,25-reductase.
17. The plant of claim 11, wherein the DNA coding sequence encodes an S- adenosyl-L-methionine-Δ24(25)-sterol methyl transferase (SMT).
18. The plant of claim 17, wherein the SMT is from plants or yeast.
19. The plant of claim 17, wherein the SMT is derived from Zea mays, Arabidopsis thaliana or Prototheca wickerhamii.
20. The plant of claim 17, wherein the SMT is yeast ERG6.
21. The plant of claim 11, which plant is resistant to an insect, nematode or pythiaceous fungus.
22. The plant of claim 11, which plant has an increased level of a cholesterol- reducing sterol.
23. The plant of claim 22, wherein the sterol is cycloartenol or sitosterol.
24. The plant according to claim 11, which plant is resistant to drought, salinity or severe cold.
25. The plant according to claim 11, which plant is a tomato, com or soybean plant.
26. A process of producing a transgenic plant comprising:
(a) transforming plant cells with a recombinant DNA molecule comprising: a promoter which functions in plants to cause the production of an RNA sequence, operably linked to a DNA coding sequence which encodes an enzyme which binds a first sterol and produces a second sterol, operably linked to a 3' non-translated region which causes the polyadenylation of the 3' end of the RNA sequence; wherein the promoter is heterologous with respect to the DNA sequence; (b) selecting transformed plant cells comprising the recombinant DNA molecule; and
(c) regenerating transgenic plants from the transformed plant cells.
27. The process of claim 26, wherein the DNA coding sequence is in the sense orientation.
28. The process of claim 26, wherein the DNA coding sequence is in the antisense orientation.
29. The process of claim 26, wherein the first sterol is selected from the group consisting of 4-methyl sterol, 9β,19-cyclopropyl sterol, Δ8-sterol, 14α-methyl sterol,
Δ23,24-alkyl sterol, Δ24,24-alkyl sterol and Δ25(27), 24-alkyl sterol.
30. The process of claim 26, wherein the first or second sterol lacks a Δ5 group.
31. The process of claim 26, wherein the DNA coding sequence encodes an enzyme selected from the group consisting of a S-adenosyl-L-methionine-Δ24(25)-sterol methyl transferase, a C-4 demethylase, a cycloeucalenol to obtusifoliol-isomerase, a 14α-methyl demethylase, a Δ8 to Δ7-isomerase, a Δ7-C-5-desaturase and a 24,25-reductase.
32. The process of claim 26, wherein the DNA coding sequence encodes an S- adenosyl-L-methionine-Δ24(25)-sterol methyl transferase (SMT).
33. The process of claim 32, wherein the SMT is from plants or yeast.
34. The process of claim 32, wherein the SMT is derived from Zea mays, Arabidopsis thaliana or Prototheca wickerhamii.
35. The process of claim 32, wherein the SMT is yeast ERG6.
36. The process of claim 26, wherein the plant is resistant to an insect, nematode or pythiaceous fungus.
37. The process of claim 26, wherein the plant has an increased level of a -cholesterol-reducing sterol.
38. The process of claim 37, wherein the sterol is cycloartenol or sitosterol.
39. The process of claim 26, wherein the plant is resistant to drought, salinity or severe cold.
40. The process of claim 26, wherein the plant is a tomato, com or soybean plant.
PCT/US1997/023495 1996-12-26 1997-12-24 Transgenic plants with modified sterol biosynthetic pathways WO1998045457A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP97953327A EP0958370A1 (en) 1996-12-26 1997-12-24 Transgenic plants with modified sterol biosynthetic pathways
CA002276087A CA2276087A1 (en) 1996-12-26 1997-12-24 Transgenic plants with modified sterol biosynthetic pathways
AU57099/98A AU724046B2 (en) 1996-12-26 1997-12-24 Transgenic plants with modified sterol biosynthetic pathways
BR9714439A BR9714439A (en) 1996-12-26 1997-12-24 Transgenic plants with modified sterol compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3392396P 1996-12-26 1996-12-26
US60/033,923 1996-12-26

Publications (1)

Publication Number Publication Date
WO1998045457A1 true WO1998045457A1 (en) 1998-10-15

Family

ID=21873233

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/023495 WO1998045457A1 (en) 1996-12-26 1997-12-24 Transgenic plants with modified sterol biosynthetic pathways

Country Status (6)

Country Link
EP (1) EP0958370A1 (en)
CN (1) CN1247569A (en)
AU (1) AU724046B2 (en)
BR (1) BR9714439A (en)
CA (1) CA2276087A1 (en)
WO (1) WO1998045457A1 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008190A2 (en) * 1998-08-03 2000-02-17 Arizona Board Of Regents On Behalf Of The University Of Arizona Sterol methyltransferase gene
WO2001023539A2 (en) * 1999-09-30 2001-04-05 E.I. Du Pont De Nemours And Company Genes encoding sterol delta-15 reductase in plants
WO2001031043A1 (en) * 1999-10-27 2001-05-03 The University Of Bristol Increasing isoprenoid biosynthesis
WO2001031027A1 (en) * 1999-10-27 2001-05-03 Unilever N.V Process for modifying plants
WO2000061771A3 (en) * 1999-04-12 2001-07-05 Monsanto Co Transgenic plants containing altered levels of sterol compounds and tocopherols
WO2001079513A2 (en) * 2000-04-14 2001-10-25 Unilever N.V. Process for modifying plants
WO2002042477A2 (en) * 2000-11-24 2002-05-30 Unilever N.V. Process for increasing the level of sterols in plants
WO2003064650A1 (en) * 2002-01-29 2003-08-07 Basf Aktiengesellschaft Method for the production of 7-dehydrocholesterol and/or the biosynthetic intermediate or subsequent products thereof in transgenic organisms
WO2004007730A1 (en) * 2002-07-16 2004-01-22 Unilever N.V. Method for modifying plants
US6822142B2 (en) 2001-01-05 2004-11-23 Monsanto Company Transgenic plants containing altered levels of steroid compounds
JP2009112245A (en) * 2007-11-06 2009-05-28 Kao Corp Method for producing 2-phenylethyl alcohol
EP2216405A1 (en) 2002-05-03 2010-08-11 Monsanto Technology LLC Speed specific USP promoters for expressing genes in plants
WO2011069953A1 (en) * 2009-12-09 2011-06-16 Basf Plant Science Company Gmbh Methods for increasing the resistance of plants to fungi by silencing the fungal smt1-gene
US8952217B2 (en) 2005-10-14 2015-02-10 Metanomics Gmbh Process for decreasing verbascose in a plant by expression of a chloroplast-targeted fimD protein
EP3205669A1 (en) 2016-02-15 2017-08-16 Brendan Patrick Purcell Composite biofabricated material
EP3473647A1 (en) 2017-06-29 2019-04-24 Modern Meadow, Inc. Yeast strains and methods for producing collagen
US11214844B2 (en) 2017-11-13 2022-01-04 Modern Meadow, Inc. Biofabricated leather articles having zonal properties
US11352497B2 (en) 2019-01-17 2022-06-07 Modern Meadow, Inc. Layered collagen materials and methods of making the same
US11913166B2 (en) 2015-09-21 2024-02-27 Modern Meadow, Inc. Fiber reinforced tissue composites

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR086406A1 (en) * 2011-05-16 2013-12-11 Basf Plant Science Co Gmbh NEMATODE RESISTANT TRANSGENIC PLANTS
CN111500624B (en) * 2020-06-30 2020-10-30 中国农业科学院生物技术研究所 Use of CrSMT genes to increase resistance of plants to biotic and abiotic stress

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5349126A (en) * 1990-10-12 1994-09-20 Amoco Corporation Process and composition for increasing squalene and sterol accumulation in higher plants
WO1997048793A1 (en) * 1996-06-21 1997-12-24 The General Hospital Corporation Plant sterol reductases and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5349126A (en) * 1990-10-12 1994-09-20 Amoco Corporation Process and composition for increasing squalene and sterol accumulation in higher plants
WO1997048793A1 (en) * 1996-06-21 1997-12-24 The General Hospital Corporation Plant sterol reductases and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GACHOTTE D ET AL.: "An Arabidopsis mutant deficient in sterol biosynthesis: heterologous complementation by ERG 3 encoding a delta 7-sterol-C-5-desaturase from yeast", PLANT J (ENGLAND) SEP 1995, 8 (3) P407-16, XP002063589 *
GRAUSEM B. ET AL.: "Functional expression of Saccharomyces cerevisiae CYP51A1 encoding lanosterol-14-demethylase in tobacco results in bypass of endogenous sterol biosynthetic pathway and resistance to an obtusifoliol-14-demethylase herbicide inhibitor.", PLANT J (ENGLAND) MAY 1995, 7 (5) P761-70, XP002063588 *

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008190A3 (en) * 1998-08-03 2000-06-08 Univ Arizona Sterol methyltransferase gene
WO2000008190A2 (en) * 1998-08-03 2000-02-17 Arizona Board Of Regents On Behalf Of The University Of Arizona Sterol methyltransferase gene
WO2000061771A3 (en) * 1999-04-12 2001-07-05 Monsanto Co Transgenic plants containing altered levels of sterol compounds and tocopherols
US7709666B2 (en) 1999-04-12 2010-05-04 Monsanto Technology Llc Transgenic plants containing altered levels of sterol compounds and tocopherols
US7009089B1 (en) 1999-09-30 2006-03-07 E.I. Du Pont De Nemours And Company Genes encoding sterol delta-14 reductase in plants
WO2001023539A2 (en) * 1999-09-30 2001-04-05 E.I. Du Pont De Nemours And Company Genes encoding sterol delta-15 reductase in plants
WO2001023539A3 (en) * 1999-09-30 2002-03-07 Du Pont Genes encoding sterol delta-15 reductase in plants
WO2001031043A1 (en) * 1999-10-27 2001-05-03 The University Of Bristol Increasing isoprenoid biosynthesis
WO2001031027A1 (en) * 1999-10-27 2001-05-03 Unilever N.V Process for modifying plants
WO2001079513A2 (en) * 2000-04-14 2001-10-25 Unilever N.V. Process for modifying plants
WO2001079513A3 (en) * 2000-04-14 2002-04-11 Unilever Nv Process for modifying plants
WO2002042477A3 (en) * 2000-11-24 2002-09-12 Unilever Nv Process for increasing the level of sterols in plants
WO2002042477A2 (en) * 2000-11-24 2002-05-30 Unilever N.V. Process for increasing the level of sterols in plants
US6822142B2 (en) 2001-01-05 2004-11-23 Monsanto Company Transgenic plants containing altered levels of steroid compounds
US7544863B2 (en) 2001-01-05 2009-06-09 Monsanto Technology Llc Transgenic plants containing altered levels of steroid compounds
US7906710B2 (en) 2001-01-05 2011-03-15 Monsanto Company Transgenic plants containing altered levels of steroid compounds
WO2003064650A1 (en) * 2002-01-29 2003-08-07 Basf Aktiengesellschaft Method for the production of 7-dehydrocholesterol and/or the biosynthetic intermediate or subsequent products thereof in transgenic organisms
US7608421B2 (en) 2002-01-29 2009-10-27 Organobalance Gmbh Method for the production of 7-dehydrocholesterol and/or the biosynthetic intermediate or subsequent products thereof in transgenic organisms
US10385375B2 (en) 2002-01-29 2019-08-20 Novozymes A/S Preparation of 7-dehydrocholesterol and/or the biosynthetic intermediates and/or secondary products thereof in transgenic organisms
EP2216405A1 (en) 2002-05-03 2010-08-11 Monsanto Technology LLC Speed specific USP promoters for expressing genes in plants
WO2004007730A1 (en) * 2002-07-16 2004-01-22 Unilever N.V. Method for modifying plants
US8952217B2 (en) 2005-10-14 2015-02-10 Metanomics Gmbh Process for decreasing verbascose in a plant by expression of a chloroplast-targeted fimD protein
JP2009112245A (en) * 2007-11-06 2009-05-28 Kao Corp Method for producing 2-phenylethyl alcohol
US8927812B2 (en) 2009-12-09 2015-01-06 Basf Plant Science Company Gmbh Methods for increasing the resistance of plants to fungi by silencing the fungal SMT1-gene
WO2011069953A1 (en) * 2009-12-09 2011-06-16 Basf Plant Science Company Gmbh Methods for increasing the resistance of plants to fungi by silencing the fungal smt1-gene
US11913166B2 (en) 2015-09-21 2024-02-27 Modern Meadow, Inc. Fiber reinforced tissue composites
EP3747900A1 (en) 2016-02-15 2020-12-09 Modern Meadow, Inc. Method for biofabricating composite material
EP3747901A1 (en) 2016-02-15 2020-12-09 Modern Meadow, Inc. Biofabricated material containing collagen fibrils
EP3205668A1 (en) 2016-02-15 2017-08-16 Brendan Patrick Purcell Method for biofabricating composite material
US10301440B2 (en) 2016-02-15 2019-05-28 Modern Meadow, Inc. Biofabricated material containing collagen fibrils
US10370504B2 (en) 2016-02-15 2019-08-06 Modern Meadow, Inc. Method for making a biofabricated material containing collagen fibrils
US10370505B2 (en) 2016-02-15 2019-08-06 Modern Meadow, Inc. Method for making biofabricated composite
EP3205666A1 (en) 2016-02-15 2017-08-16 Brendan Patrick Purcell Method for making a biofabricated material containing collagen fibrils
US10519285B2 (en) 2016-02-15 2019-12-31 Modern Meadow, Inc. Method for biofabricating composite material
EP3205669A1 (en) 2016-02-15 2017-08-16 Brendan Patrick Purcell Composite biofabricated material
EP3205667A1 (en) 2016-02-15 2017-08-16 Brendan Patrick Purcell Biofabricated material containing collagen fibrils
US11001679B2 (en) 2016-02-15 2021-05-11 Modern Meadow, Inc. Biofabricated material containing collagen fibrils
US11542374B2 (en) 2016-02-15 2023-01-03 Modern Meadow, Inc. Composite biofabricated material
US11286354B2 (en) 2016-02-15 2022-03-29 Modern Meadow, Inc. Method for making a biofabricated material containing collagen fibrils
US11530304B2 (en) 2016-02-15 2022-12-20 Modern Meadow, Inc. Biofabricated material containing collagen fibrils
US11525042B2 (en) 2016-02-15 2022-12-13 Modern Meadow, Inc. Composite biofabricated material
EP3473647A1 (en) 2017-06-29 2019-04-24 Modern Meadow, Inc. Yeast strains and methods for producing collagen
US11214844B2 (en) 2017-11-13 2022-01-04 Modern Meadow, Inc. Biofabricated leather articles having zonal properties
US11352497B2 (en) 2019-01-17 2022-06-07 Modern Meadow, Inc. Layered collagen materials and methods of making the same

Also Published As

Publication number Publication date
AU724046B2 (en) 2000-09-07
CA2276087A1 (en) 1998-10-15
BR9714439A (en) 2000-03-21
EP0958370A1 (en) 1999-11-24
AU5709998A (en) 1998-10-30
CN1247569A (en) 2000-03-15

Similar Documents

Publication Publication Date Title
AU724046B2 (en) Transgenic plants with modified sterol biosynthetic pathways
US5589619A (en) Process and composition for increasing squalene and sterol accumulation in higher plants
Hey et al. Enhanced seed phytosterol accumulation through expression of a modified HMG‐CoA reductase
US7906710B2 (en) Transgenic plants containing altered levels of steroid compounds
Kim et al. Arabidopsis cyp51 mutant shows postembryonic seedling lethality associated with lack of membrane integrity
AU763969B2 (en) Methods and compositions for modifying levels of secondary metabolic compounds in plants
Ohnishi et al. Tomato cytochrome P450 CYP734A7 functions in brassinosteroid catabolism
Wang et al. Overexpression of a cytoplasm-localized allene oxide synthase promotes the wound-induced accumulation of jasmonic acid in transgenic tobacco
NZ325676A (en) A method for regulation of plant lignin composition
WO1999019493A2 (en) Cytochrome p-450 constructs and methods of producing herbicide-resistant transgenic plants
AU2002245219A1 (en) Transgenic plants containing altered levels of steroid compounds
Kumar et al. Lanosterol synthase-like is involved with differential accumulation of steroidal glycoalkaloids in potato
US5959180A (en) DNA sequences from potato encoding solanidine UDP-glucose glucosyltransferase and use to reduce glycoalkaloids in solanaceous plants
US7750210B2 (en) Compositions with increased phytosterol levels obtained from plants with decreased triterpene saponin levels
US6153815A (en) DNA sequences from brassicaceae encoding squalene epoxidase and process of raising squalene levels in plants therewith
US20020148006A1 (en) Transgenic plants with modified sterol compositions
US6768043B2 (en) Das5, a P450 protein involved in the brassinosteroid biosynthesis pathway in plants
US7279619B2 (en) Methods and compositions for modifying levels of secondary metabolic compounds in plants
US20030166202A1 (en) P450 Monooxygenases of the cyp79 family
AU720590B2 (en) Novel plant steroid 5alpha reductase, DET2
WO2004007730A1 (en) Method for modifying plants
WO2024003012A1 (en) Saponarioside biosynthetic enzymes
CA2305864C (en) Transgenic reduction of sinapine in crucifera
Kazmi The effects of Arabidopsis thaliana Sulfotransferase 2a (AtST2a) over-expression on tuber formation
CH OH y—CHACONINE

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97181954.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 57099/98

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2276087

Country of ref document: CA

Ref document number: 2276087

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/006066

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1997953327

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1997953327

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 57099/98

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1997953327

Country of ref document: EP